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Abstract 
The human bronchial epithelium acts as a protective barrier preventing microorganisms from 
entering the airways and has a great impact on biological mechanisms that causes airway 
diseases, such as asthma. Established in vitro airway models often consist of an epithelial 
layer cultured in two-dimensional (2D) monolayer in an air-liquid interface (ALI); however, 
great attention has to be paid to the composition of the growth medium in order to achieve 
the system to be sufficiently differentiated and functional.  
Studies have shown that fibroblasts regulate proliferation and differentiation of the epithelial 
cells while epithelial cells stimulate fibroblast migration and proliferation. In this work the 
aim was to engineer an in vitro bronchial mucosa model consisting of an epithelium and an 
underlying fibroblast layer separated by a biodegradable electrospun poly-L-lactic acid 
(PLLA) membrane.  Electrospinning is a widely used scaffold fabrication technique and was 
chosen due to the ability of achieving highly porous (up to 90%) scaffolds with high surface 
area to volume ratio and due to its cost-effectiveness. Electrospun nanofibre PLLA 
membranes were used as as a substitute for the basement membrane of the bronchial mucosa 
and were coated with fibronectin (FN) to improve cell adhesion.  
 
Human bronchial epithelial cells (HBEpiCs) were seeded on the apical side of the membrane 
and fibroblasts on the basal side. The two cell types were co-cultured in ALI for 2 weeks 
and scanning electron microscopy (SEM) and immunostaining techniques were used to 
observe and analyse cellular behaviour of the cells and protein secretion of collagen type IV 
(Col IV) and laminin (LM). PLLA membranes consisting of non-beaded nano-fibres with a 
diameter of around 240nm were produced and coated with FN to improve cell attachment.  
 
When HBEpiCs were cultured on these membranes in ALI, the cells maintained their cellular 
polarity as well as the morphological and functional properties of bronchial epithelial cells. 
Both cell types attached and grew on FN coated PLLA surfaces compared to non-FN coated 
surfaces. After 2 weeks of co-culture tight junctions between the HBEpiCs were detected 
with E-cadherin staining and ciliated cells were observed with SEM. Fibroblasts seeded on 
the basal side of the PLLA membrane brought to the system a substantial improvement in 
epithelial cells differentiation in comparison to the HBEpiC cultured without a fibroblast 
layer. Col IV and LM secretion from both HBEpiCs and fibroblasts was confirmed with 
immunostaining after 1 week of culture. 
 iii 
Additionally, this research aimed to investigate the possibilities of converting the bronchial 
mucosa model into an in vitro asthma model. This was done by introducing the cytokine 
Interleukin 13 (IL-13) to the cells as IL-13 is known to play a key role in asthma. IL-13 plays 
an important role in the pathogenesis of asthma by increasing the differentiation of mucus 
secreting epithelial cells and causing mucus hypersecretion leading to poor mucociliary 
clearance in the airways. The gold standard for treating asthmatic attacks currently includes 
inhaled glucocorticosteroids, which help the inflammatory reaction such as by reducing 
mucus hypersecretion. Dexamethasone is a type of corticosteroid and inhibits MUC2 and 
MUC5AC protein expression in some airway epithelial cell lines. However, the various 
airway epithelial cell lines and primary animal airway epithelial cells respond differently to 
dexamethasone, hence, the effect of dexamethasone on human bronchial epithelial cell 
mucin secretion was studied in this research. 
 
IL-13 was introduced to the in vitro bronchial mucosa model to develop an in vitro asthma 
model. ELISA was used to quantify MUC5AC expression and SEM was used to assess the 
ciliation of HBEpiCs. Poor ciliation of the HBEpiC was observed while the mucus secretion 
of the cells increased after 2 and 4 weeks of ALI co-culture. This suggest that IL-13 induces 
mucus hypersecretion and causes airway remodelling by reducing ciliation of epithelial cells. 
The ELISA showed low MUC5AC levels for epithelial cells treated with dexamethasone in 
both the in vitro asthma model and bronchial model. This reduction in MUC5AC secretion 
observed in the dexamethasone-treated HBEpiCs was similar to the reaction to inhaled 
glucocorticosteroids used for treating asthma, however, the dexamethasone did not improve 
the re-ciliation of the HBEpiCs.  
 
With this research, an in vitro bronchial mucosa model mimicking the in vivo cell 
morphology and the microenvironment in the basement membrane was established 
successfully by using ALI co-culture system and FN coated electrospun PLLA membranes. 
This work suggests an ALI co-culture system that would be suitable for acting as an in vitro 
disease model for studying airway diseases such as asthma and could be a possible model 
for asthma drug screening. The established in vitro bronchial mucosa model could be 
suitable for investigating and understanding key mechanisms involved in airway diseases 
such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and airway repair. 
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1. Introduction 
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1.1 The Mucosa 
The mucosa is a mucous membrane that lines the lumen of various organs in the body. 
Consisting of an epithelial layer, a basement membrane and loose connective tissue known 
as lamina propria (Figure 1.1) (Gartner e Hiatt, 2007a; Gartner P. et al., 2011) (Weiss, Leon, 
1988b; Gartner e Hiatt, 2007a; Gartner P. et al., 2011), the mucosa acts as a protective 
membrane against external microorganisms and antigens, and injury to the underlying 
tissues (Gartner e Hiatt, 2007c; Gartner, L. P. et al., 2011). The epithelium is an avascular 
tissue and receives nutrients through diffusion from the underlying basement membrane on 
which the epithelial cells rest and is categorised based on the amount of epithelial cell layers 
and cell morphology. Simple epithelium is characterised by a single layer of epithelial cells, 
while stratified epithelium consists of two or more cell layers. The shape of the cells 
determines whether the epithelium is squamous, cuboidal or columnar (Figure 1.2). Due to 
their apical–basal polarity, epithelial cells are polarised cells, with an apical domain facing 
the lumen of organs and a basolateral domain that is in contact with the underlying basement 
membrane or with neighbouring epithelial cells. Many epithelial cells have 5–15-m long 
motile, hair-like projections of the plasma known as cilia, which are involved in moving 
substances across the epithelial surface. Cilia beat towards one direction systematically 
(Gartner e Hiatt, 2007c). 
Intercellular interactions and adhesions, known as junctional complexes, occur in the lateral 
membrane domain. There are three types of junctional complexes (Weiss, L., 1988; Gartner 
e Hiatt, 2007c): 
• Occluding junctions that function as a restriction barrier that inhibits intercellular 
material exchange. 
• Anchoring junctions (adherens junctions) that maintain intercellular adherence and 
cell–basal lamina adherence. 
• Communication junctions (gap junctions) that prevent intercellular movement of 
ions and signalling molecules and that provide both electrical and metabolic coupling 
of adjacent cells. 
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Figure 1.1. Macroscopic overview of mucosa tissue showing the ciliated epithelium and 
mucin-secreting epithelial cells resting on the basement membrane and the underlying loose 
connective tissue, i.e. lamina propria. 
 
 
 
 
Figure 1.2. The classification of epithelial cells according to shape and organisation. Figure 
adapted from Martini et al. (Martini et al., 2012a). 
 
From the apical surface and towards the basolateral membrane, the three main components 
of the junctional complex are found: zonula occludens, also known as tight junctions, zonula 
adherens, and desmosomes (macula adherens). Zonula occludens are found at the most 
apical pole and form a belt-like junction that encircles the entire epithelial cell (Figure 1.3). 
Adjacent cells are joined through the fusion of transmembrane proteins such as claudins and 
occludins, which form a seal between the adjacent intercellular spaces. The tightness of these 
junctions depends on the number of transmembrane protein strands. This junctional complex 
inhibits protein movement from the apical domain to the basolateral domain and prevents 
transcellular movement of water-soluble molecules. Transmembrane proteins such as 
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cadherin bind with actin through the anchoring proteins, -actinin and vinculin, thus binding 
the cortical cytoskeleton of one cell to another (Figure 1.3). These adherens junctions give 
rise to lateral adhesions between the epithelial cells and contribute to the structural integrity 
of the epithelium (Weiss, L., 1988; Gartner e Hiatt, 2007c; Alberts et al., 2008).  
 
 
Figure 1.3. Overview of different cell junctions including. Figure adapted from Alberts et 
al.  (Alberts et al., 2008).  
The basement membrane is the basal extracellular matrix (ECM) on which the epithelium 
rests and is synthesised by the epithelium and the underlying lamina propria (Weiss, L., 
1988; Gartner e Hiatt, 2007c; Gartner, L. P. et al., 2011). The basement membrane consists 
of basal lamina, which consists of lamina lucida and lamina densa, anchoring proteins, 
including type VII collagen (Col VII) and lamina reticularis. Col VII anchoring fibrils are 
part of the supracellular anchoring network in the basement membranes ensuring attachment 
of the epithelial cells to the underlying ECM. Col VII binds to laminin 5 in lamina densa and 
type I collagen (Col I) fibres in the lamina reticularis. Type IV collagen (Col IV), laminin 
(LM), entactin (also known as nidogen) and perlecan are the four main components of the 
basement membrane. Col IV comprises 50% of the basement membrane; LM is the second 
most prominent non-collagenous protein in the membrane. Col IV and LM networks form 
the basic basement membrane framework; entactin and perlecan stabilise the Col IV/LM 
scaffold by connecting the Col IV and LM networks (Lebleu et al., 2007). The lamina 
propria is thin underlying loose connective tissue of the basement membrane and consists of 
various cells, including fibroblasts, lymphocytes, macrophages, plasma cells and mast cells; 
protein fibres are loosely organised and scarce (Gartner, L. et al., 2011).  
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1.1.1 Bronchial Mucosa  
The pulmonary airway consists of the trachea, a cartilaginous tube that extends to the left 
and right primary bronchi. The primary bronchi branch into the lungs and form smaller 
airways also known as the intrapulmonary bronchi. These further divide into secondary and 
tertiary bronchi within the lungs. The cartilage surrounding the bronchi decreases 
progressively as the bronchi enter the lungs, while the smooth muscles become more 
abundant. The lumen of the respiratory tract, especially the bronchial mucosa, is the main 
tissue of interest in this project. The mucosa includes a pseudostratified columnar epithelium 
that is divided into ciliated epithelial cells and mucin secreting goblet cells aiding mucus 
clearance from the airways (Figure 1.4). The epithelium rests on a thick basement membrane 
comprised of mainly Col IV and LM and the underlying fibroblast-abundant lamina propria 
(Alberts et al., 2008).   
The epithelium acts as a protective barrier, preventing microorganisms from entering the 
airway, and has a major impact on the biological mechanisms that cause airway diseases, 
such as asthma (Mauad et al., 2007; Parker et al., 2010). In the present project, the bronchial 
mucosa, especially the bronchial epithelium, is of great interest because of the similarity of 
its cell morphology with other epithelium, such as oviduct epithelium, due to the cell shape 
and the presence of both ciliated and secretory epithelial cells (Parker et al., 2010; Martini 
et al., 2012a).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. Scanning electron microscopy of the tracheal epithelium. CC = ciliated cells, GC 
= goblet cells. SEM image was adapted from Johnson et al. (Johnson, 1991). 
CC 
CC GC 
GC 
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1.1.2 Oviduct Mucosa 
 
Human oviduct mucosa is another mucosa type of interest in this research project as the 
initial aim of this research was to develop an in vitro human oviduct mucosa consisting of 
an oviduct epithelium and an underlying connective tissue layer. Primary human oviduct 
epithelial cells (HOEpiCs) were preferred as primary cells represent the in vivo morphology 
more closely than cell lines and are more suited for clinical conclusions. However, HOEpiCs 
are not commercially available; hence, a need to harvest HOEpiCs from donors was 
identified early in the project. A collaboration with Skive Fertility Clinic and the Faculty of 
Health at Aarhus University was established for clinical support and to investigate the 
possibilities of retrieving HOEpiCs from patients undergoing hysterectomy or 
salpingectomy. Ethical approval from the Regional Ethical Committee, the Danish Data 
Protection Agency, was applied to gain approval to recruit 30 patients willing to donate 
oviducts removed during hysterectomy or salpingectomy. Due to the long processing times 
for such applications and establishing a collaboration with clinicians, the scope of the project 
was extended to investigating engineering approaches of in vitro human mucosae such as 
the in vitro bronchial mucosa model presented. The bronchial mucosa was chosen due to the 
similarities of bronchial and oviduct epithelial cell morphology, including cell shape and the 
presence of both ciliated and secretory epithelial cells (Johnson, 1991; Martini et al., 2012b). 
Nevertheless, it was possible to obtain donor oviducts from patients in Denmark, and 
currently there is an on-going project aiming to develop in vitro oviduct mucosa suing ALI 
culture system and HOEpiCs obtained from donor oviducts. 
 
The female reproductive system consists of the uterus, two oviducts and two ovaries 
(Pauerstein et al., 1974; Weiss, Leon, 1988b). The uterus is located between the bladder and 
the rectum. Each oviduct is interconnected to the upper sides of the uterus and have another 
opening out to the abdominal cavity located near the ovaries. These openings are funnel- or 
trumpet-shaped and equipped with fimbriae, finger-like outgrowths (Pauerstein et al., 1974; 
Martini et al., 2012b). Each is 10–15-cm long and has a smooth surface and soft texture. The 
outer diameter ranges from a few millimetres to a maximum of 1 cm and increases towards 
the opening ejecting to the abdominal cavity (Terranova, 2003; Bahathiq e Ledger, 2010). 
The oviduct is divided into five regions: the pars uterina, which is the part of the tube within 
the uterine wall, the isthmus, the ampulla, the infundibulum, which is the opening towards 
the abdominal cavity, and the fimbriae. The oviducts are supplied with arterial blood through 
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the uterine and ovarian arteries. The pars uterina and approximately two-thirds of the oviduct 
are supplied with blood through uterine arteries; ovarian arteries supply the remaining 
portion of the oviduct. A capillary network can be found in the mucosal layer, muscular layer 
and tunica serosa (Martini et al., 2012b). is similar to that of tubular organs, consisting of 
three major layers from the lumen to periphery: mucosal layer, muscular layer, and tunica 
serosa. The tunica mucosa forms a complex lumen of branched and longitudinal mucosal 
folds. This layer consists of simple columnar epithelium, which lines the oviduct lumen, a 
basement membrane and lamina propria (Weiss, Leon, 1988a; b; Gartner e Hiatt, 2007b; 
Gartner P. et al., 2011). The epithelium comprises a mixture of ciliated and secretory cells 
(Pauerstein et al., 1974; Eddy, 1982; Gartner e Hiatt, 2007b; Gartner P. et al., 2011). The 
cells of the oviduct have a random pattern and distribution, hence it is possible to identify 
areas in which one cell type is more abundant in relation to the other (Eddy, 1982).  
 
1.2 Tissue Engineering  
Tissue engineering is a cell-based theory and an emerging interdisciplinary field that 
involves biology, engineering and medical science and that aims to regenerate healthy and 
functional human tissue to replace diseased or damaged tissue. The tissue is engineered by 
combining cells with naturally derived or synthetic scaffolds (Dhandayuthapani et al., 2011; 
Lanza et al., 2011). Tissue engineered applications can be implanted in the human body or 
used to generate in vitro tissue models to substitute conventional cell monocultures. 
Currently, numerous tissue engineered applications are available, mainly for skin, cartilage, 
bone and blood vessels (Lanza et al., 2011; Kamel et al., 2013).  
Tissue engineering of the airways has been widely investigated over the last 40 years with 
focus on regenerating airway models that can support the generation of well-differentiated 
epithelium and facilitate mucocilliary clearance. Despite the extensive research aiming to 
develop functional airway models for clinical use, the gold standard treatments for tracheal 
stenosis, carcinoma or injury include tracheal resection and reconstruction or use of tracheal 
stents incorporating biodegradable polymers. Biodegradable polymer scaffolds were of 
interest for the current research as such scaffolds have the potential of being used as artificial 
grafts to regenerate functional airway epithelium for patients with damage to their trachea 
due to trauma, tracheal stenosis or carcinoma. 
Tracheal stenosis is a condition caused by congenital anomalies, tumour or fistulas caused 
by injury, surgery, or infection and effects 1 in 200,000 people yearly (Nouraei et al., 2007). 
Treatment of tracheal stenosis depends on the effected length of the trachea tracheal and 
involves surgical repair such as tracheal resection and reconstruction. Autologous donor 
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tissue such as buccal mucosa graft, pericardium, and rib cartilage are currently used for 
tracheal reconstruction aiming to increase the airway lumen. However, these autologous 
donor grafts can be difficult to obtain from the patient and are challenging to shape. 
Biocompatible scaffolds offer a potential alternative solution to autologous donor graft 
used for tracheal reconstruction. Scaffolds for tissue engineered airway models must be 
biocompatible, have high mechanical strength, be flexible and porous to support 
vascularisation and cell growth. Many studies have investigated the use of decellularised 
scaffolds as well as synthetic ones. Elliott et al.(2012) used a decellularised cadaveric donor 
tracheal scaffold seeded with bone marrow mesenchymal stem cells and patches of tracheal 
epithelium. The graft was implanted into a 12-year-old patient diagnosed with congenital 
tracheal stenosis and within 1 week post surgery, re-vascularisation of the graft was observed 
while regenerated epithelium was achieved one year after implantation (Elliott et al., 2012). 
The patient gained normal function of the airway after 2 years.  
Use of synthetic or naturally derived biodegradable scaffolds for airway repair have also 
been investigated in both animals and human. Research on biodegradable airway stents is 
currently limited, however, some studies using biodegradable stents mainly made of 
polydioxanone have been reported (Vondrys et al., 2011; Anton-Pacheco et al., 2014; Serio 
et al., 2014). However, recurrence of tracheal stenosis was reported 4-5 months after 
implantation in patients due to degradation of the stents. Saito et al. (2002) used tubular 
knitted PLLA airway stents in rabbits and investigated the biocompatibility and mechanical 
strengths of the stents when compared to commonly used silicone airway stents. The 
degradation time of the PLLA airway stents was approximately 14 months and the 
mechanical strength of the stents could be increased as function of their diameter (Saito et 
al., 2002).  
 
1.2.1 In Vitro Airway Models  
Using biodegradable scaffolds for in vitro human tissue models is considered as first step to 
investigate their suitability for clinical use. As in vitro human airway tissue models are more 
representative models of the in vivo tissues, the interaction, such as cellular-scaffold 
interaction, tissue generation, and biodegradability characteristics can be better understood 
(Bogan et al., 2016). Most of the established in vitro airway models use air–liquid interface 
(ALI) culture systems consisting of cell culture inserts with porous polymer membranes.  
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Figure 1.5. Graph showing number of published studies on in vitro airway models over a 
period of 20 years (1998-2018). 
 
Figure 1.5 shows an overview of key studies on in vitro airway models using the ALI-based 
culture systems over a period of 20 years. Most of these studies use commercially available 
cell culture insert containing porous non-degradable membranes, often made of PET or 
PFET, to create the air-liquid interface culture system. Parker et al. (2010) investigated ALI 
co-culture of primary bronchial epithelial cells and fibroblasts using such collagen-coated 
non-degradable membrane, Transwell cell culture inserts. They established a long-term, 28-
day ALI culture model consisting of a polarised and well-differentiated epithelium with 
mucociliary function (Parker et al., 2010). Various researchers have investigated the 
possibilities of using other biocompatible scaffolds for the ALI culture systems (Table 1.1).  
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Table 1.1. Overview of key studies that have used ALI culture system to engineer in vitro 
airway models  
 Cell type  Scaffold Key findings  
 
Chakir et al. (2001) Human bronchial 
epithelial cells  
 
Human bronchial 
fibroblasts  
 
 
Human T lymphocytes 
 
 
Bovine type I 
collagen gel 
entrapped with 
fibroblasts 
12 days ALI culture system that 
supports epithelial cell differentiation 
to mucin secreting epithelial cells but 
did not promote ciliation of epithelial 
cells. 
 
  
 
Le Visage et al. 
(2004) 
Human respiratory 
epithelial cells  
 
Human adult 
mesenchymal stem 
cells  
Transwell cell 
culture 
membranes 
Increased mucin secretion of the 
epithelial cells when co-cultured with 
mesenchymal stem cells indicating 
the interaction between airway 
epithelial cells and mesenchymal 
stem cells may influence the 
differentiation of epithelial cells into 
mucin secreting cells. 
 
 
Coraux et al. (2005) Murine embryonic 
stem cells  
Millicel-HA 
porous 
membranes with 
or without type I 
collagen coating. 
 
 
Type I collagen coated membranes 
support murine embryonic stem cells 
into non-ciliated secretory Clara cells. 
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Pfenninger et al. 
(2007) 
Human respiratory 
epithelial cells  
 
Human nasal 
chondrocytes 
 
CellagenTM disc 
(collagen 
membranes) 
The collagen membranes and 
chondrocytes support cell 
differentiation of basal cells to goblet 
cells.  
 
Ciliation of the epithelial cells could 
not be observed. 
 
 
BéruBé et al. (2008) Normal human 
tracheal/bronchial 
tissue 
EpiAirwayTM 
tissue 
The study showed that the 
commercially available EpiAirwayTM 
tissue model is a suitable in vitro 
airway model for toxicity screening 
studies and provides comparable 
human in vivo toxicological 
responses of tobacco smoke 
components. 
 
 
Parker et al. (2010) Primary human 
bronchial epithelial 
cells 
 
Human bronchial 
fibroblasts 
 
 
Collagen coated 
Transwell cell 
culture 
membranes 
Established a long-term, 28-day ALI 
culture model consisting of a 
polarised and well-differentiated 
bronchial epithelium with 
mucociliary function. 
 
 
BéruBé et al. (2014) Normal human 
bronchial epithelium 
(NHBE)  
 
Primary human 
hepatocytes 
Millipore or 
Transwell cell 
culture 
membrane  
Developed and patented a co-culture 
model, Metabo-Lung, consisting of 
co-cultured primary human 
hepatocytes and NHBE. The study 
showed that with Metabo-Lung it is 
possible to analyse the effect of 
biotransformation of xenobiotic 
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agents has on the function of liver or 
lung.  
 
Preliminary study with Metabo-Lung 
have shown compounds exposed to 
bronchial epithelial cells are capable 
of passing the epithelial barrier and 
metabolised by underlying 
hepatocytes. 
 
 
Mahoney et al. 
(2016) 
Porcine 
tracheobronchial 
epithelial (PTBE) 
Electrospun 
poly( -
caprolactone) 
(PCL)/chitosan 
nanofibre 
scaffolds 
1 week culture of PTBEs on the 
electrospun PCL/chitosan scaffolds 
did not induce cytotoxicity of the 
epithelial cells. 
 
 
 
 
Shojaie et al. (2016) Human 
tracheobronchial 
epithelial cells (hTEC)  
 
Human dermal 
fibroblasts  
 
Small intestine 
submucosa (SIS-) 
scaffolds  
Developed a long-term 3D culture 
system consisting of well-
differentiated airway epithelium 
including basal cells, mucus secreting 
goblet cells and ciliated cells.  
 
 
Chen et al. (2016) Primary ovine trachea 
epithelial 
Spray coated 
non-woven 
polycarbonate 
urethane (PCU) 
cover 
PCU covers support cell adhesion and 
proliferation of the epithelial cells.  
 
PCU covers are suggested to be 
suitable as polymer cover of airway 
stents and did not have adverse effect 
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on the mechanical properties of the 
stents.  
 
 
Several researchers have used collagen scaffolds such as Chakir et al. (2001) who engineered 
an in vitro bronchial mucosa using human bronchial epithelial cells and fibroblasts isolated 
from normal or asthmatic bronchial biopsies (Chakir et al., 2001). The fibroblasts were 
entrapped in bovine type I collagen gels and cultured for four days prior to seeding the 
epithelial cells onto the gels. T lymphocytes retrieved from the peripheral blood of asthmatic 
patients was added in the bottom chamber of the ALI culture setup. The T cells were 
harvested and immunostained for IL-5 to investigate any significant differences in the 
amount of IL-5 produced by the T cells in the engineered normal versus asthmatic in vitro 
bronchial mucosa model. The presence of IL-5 was higher (87%) in the asthmatic model 
than the normal model (2%). With histology assays, the study confirmed the presence of 
mucus secreting in some of the epithelial cells and underdeveloped ciliae in both engineered 
bronchial mucosa models (normal and asthmatic). Although this study presented a new 
approach for tissue engineering in vitro airway model including a disease model, there was 
no indication on whether this model is suitable as a long-term culture model. Long-term ALI 
culture model have been shown to be ideal to support epithelial cell differentiation and 
maintain an in vivo–like morphology of the epithelium (Parker et al., 2010; Miessen et al., 
2011; Chen et al., 2013). Similar to Chakir et al. (2001), Vaughan et al. (2006) also used 
type I collagen gels to entrap human embryonic lung fibroblasts and seeded immortalised 
human bronchial epithelial cells onto the gels and raised in ALI. Ciliated, goblet and basal 
bronchial epithelial cells were observed with histology and immunostaining (Vaughan et al., 
2006). Collagen gels entrapped with fibroblasts mimick the in vivo 3D environment of the 
ECM compared to conventional 2D culture models. However, unlike the in vivo ECM these 
gel-based ALI culture models expose the gel scaffold containing fibroblasts to air and not 
only the epithelial layer. Electrospun membranes for ALI culture systems have also been 
investigated as potential membranes instead commercially available membranes such as 
Transwell inserts. An example of such electrospun membrane is a biphasic polyethylene 
terephthalate (PET) scaffold that has been used to co-culture a Calu-5 human bronchial 
epithelial cell line with the MRC5 fibroblast cell line (Morris et al., 2014). The scaffold 
consists of nanoPET and microPET fibres, and the study showed better proliferation of Calu-
5 cells on the nanofibre portion of the scaffold, creating a polarised epithelium after 2 weeks’ 
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co-culture with MRC5 cells in an ALI culture system. The MRC5 cells migrated and 
proliferated better in the microfibre portion of the scaffold. Natural derived scaffolds such 
as decellularised rat lung scaffolds have been used by Shojaie et al. (2016) to develop 
embryonic stem cell-derived mouse airway epithelium (Shojaie et al., 2016). Other natural 
derived scaffolds used for airway mucosa regeneration includes the small intestine 
submucosa without mucosa (SIS-) scaffold (Steinke et al., 2014). Although non-degradable 
membranes are used for most in vitro airway models, there are few studies using 
biodegradable porous membranes including Chen et al. (2016) and Mahoney et al. (2016) 
(Chen et al., 2016; Mahoney et al., 2016). Mahoney et al. (2016) have developed electrospun 
nanofibre scaffolds using poly(-caprolactone) (PCL) and using depolymerised chitosan. 
Porcine tracheabronchial epithelial cells were seeded on the electrospun membranes to 
analyse the cytotoxicity of the PCL/chitosan scaffolds when compared to the PET 
membranes of Transwell cell culture inserts. After 1 week of culture the study concluded 
that the electrospun PCL/chitosan membranes did not induce cytotoxicity of the epithelial 
cells. While Mahoney et al. (2016) have produced potential biodegradable electrospun 
membrane, further studies is needed to examine the whether their membrane is suitable for 
a long-term in vitro airway model cultured in an ALI culture system. Chen et al. (2016) have 
also investigated the use of biodegradable scaffolds for ALI culture systems using non-
woven porous polycarbonate urethane (PCU) covers. The aim of the study was to investigate 
if PCU covers produced by using spray coating technique were suitable for tissue engineered 
airway stents. Covers with high porosity and glucose permeability were produced. Primary 
ovine trachea epithelial cells were cultured on the a in ALI for 21 days to evaluate the cell 
adhesion and proliferation of the epithelial cells cultured on PCU covers. The study also 
investigated the radial force of PCU covered airway stents to ensure that the covers did not 
have adverse effect on the mechanical properties of the stents. Chen et al. (2016) showed 
that the PCU covers supports airway epithelial cell adhesion and proliferation in vitro using 
ALI culture setup. Furthermore, the study concluded that in vivo studies using PCU covered 
airway stents in healthy sheep is needed to investigate the biocompatibility and functionality 
of the stents. 
As a result of numerous researches of in vitro airway models, there are currently a few 
commercially available in vitro airway models including EpiAirwayTM by Mattek 
Corporation. EpiAirway is an in vitro airway model consisting of well differentiated normal 
human tracheal/bronchial tissue cultured on microporous membrane inserts in ALI which 
has been used by Balharry et al. (2008) to study the toxicity of inhaled tobacco smoke 
compounds (Balharry et al., 2008). The study analysed the toxicological response of the 
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EpiAirway tissue when exposed to tobacco smoke components such as nicotine, cadmium, 
formaldehyde and urethane. Balharry et al. (2008) concluded that the EpiAirway model as a 
suitable in vitro airway model for toxicity screening studies and provides comparable human 
in vivo toxicological responses of tobacco smoke components. 
In 2014, Prytherch et al. (2014) presented a novel in vitro lung-liver biotranformation model, 
Metabo-LungTM which was patented. Metabo-Lung consists of co-cultured primary human 
hepatocytes and normal human bronchial epithelial cells co-cultured in ALI on the apical 
side of commercially available cell culture inserts such as Millipore and Transwell inserts. 
With this model it is possible to analyse the effect of biotransformation of xenobiotic agents 
has on the function of liver or lung. Preliminary study done by Prytherch et al. (2014) have 
shown compounds exposed to bronchial epithelial cells are capable of passing the epithelial 
barrier and metabolised by underlying hepatocytes (Prytherch e Berube, 2014).  
 
To improve cell proliferation and differentiation of bronchial epithelial cells several studies 
have established co-cultures of epithelial cells and other cell types such as fibroblasts, 
mesenchymal stem cells, and chondrocytes. Kobayashi et al. (2006) and Myerburg et al. 
(2007) have both shown the importance of fibroblasts in regulating proliferation, 
differentiation, and mucin secretion of airway epithelial cells (Kobayashi et al., 2006; 
Myerburg et al., 2007). Furthermore, fibroblasts produce various types of growth factors, 
including fibroblasts growth factor, epidermal growth factor, and keratinocyte growth factor 
which all play a role in the proliferation of epithelial cells (Shoji et al., 1990; Goto et al., 
1999). Le Visage et al. (2004) studied the effect adult bone marrow mesenchymal stem cells 
have on airway epithelial cells using and ALI long-term co-culture (Le Visage et al., 2004). 
Mesenchymal stem cells were seeded on the basal side of Transwell cell culture inserts and 
normal human bronchial epithelial cells were seeded on the apical side and raised in ALI. 
The study showed an increased mucin secretion of the epithelial cells co-cultured with 
mesenchymal stem cells over a period of 25 days of in vitro ALI co-culture. This study 
indicates that the interaction between airway epithelial cells and mesenchymal stem cells 
may influence the differentiation of epithelial cells into mucin secreting cells. Pfenninger et 
al. (2007) have also established an in vitro airway models consisting of human respiratory 
epithelial cells and human nasal chondrocytes cultured in three different co-culture systems 
where epithelial cells were seeded on chondrocytes pellets, on native articular cartilage 
chips, or on commercially available collagen membranes, CellagenTM disc from MP ICN 
Biomedicals (Pfenninger et al., 2007). The collagen membranes were used to mimick the 
basement membrane in vitro and an ALI co-culture system with the membranes seeded with 
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airway epithelial cells on the apical side of the membrane and chondrocytes on the basal side 
of the membrane was developed. The ALI co-culture system using collagen membranes 
indicated cell differentiation of basal cells to goblet cells while ciliation of the epithelial cells 
was not observed. The study suggests the lack of ciliation could be due to absence of 
fibroblasts secreted growth factors. However, the duration of the ALI co-culture was 12 days 
which could have been too short culture duration as other studies have suggested longer ALI 
culture period facilitates differentiation of epithelial cell as mentioned above. Pfenninger et 
al. (2007) concluded various factors to be important to establish an in vitro airway tissue 
including an ALI culture system, fibroblasts secreted extracellular factors, and an alternative 
for the basement membrane such as collagen membranes to ensure epithelial cell attachment 
and separation of the epithelium and the underlying connective tissue. Some studies have 
aimed to engineer artificial basement membranes for ALI based in vitro epithelium models 
in order to mimick the in vivo microenvironment of the epithelial layer. One of these studies 
includes electrospun bi- and tri-layer scaffolds consisting of micro-porous PLLA 
electrospun onto nano-porous poly hydroxybutyrate-co- hydroxyvalerate (PHBV) scaffolds 
developed by Bye et al. (Bye et al., 2013). The scaffolds were used to separate tissue layers 
such as bone forming tissue and keratinocytes from fibroblasts. The tri-layer scaffolds were 
also used as an alternative for basement membrane in in vitro skin models by Bye et al. (Bye 
et al., 2014). Dermal fibroblast were seeded inside the scaffolds and cultured for 2 days prior 
to seeding keratinocytes onto the scaffolds. An ALI culture system was established after 
additional 2 days of culture exposing the keratinocytes to air and the ALI culture was 
extended to 7 or 14 days. In addition Bye et al. (2014) developed an electrospun PLLA 
monolayered scaffold. Fibroblasts were seeded onto the basal side of the monolayer 
scaffolds while the keratinocytes were seeded on the apical side of the scaffolds and cultured 
in ALI. The study concluded that the PHBV nanofibres of the tri-layer scaffolds supported 
cell attachment and proliferation of the keratinocytes compared to the mono-layer PLLA 
scaffolds. This study indicates the importance of using nano-fibrous scaffolds when 
engineering artificial basement membrane as these scaffolds create the separation between 
the epithelial layer and the underlying connective tissue and hinders migration of epithelial 
cells and stromal cells.  
  
Apart from in vitro healthy airway models, many studies have also investigated the 
possibilities of developing airway disease models mimicking the characteristics and 
phenotype of some of the most common pulmonary diseases, such as asthma and chronic 
obstructive pulmonary disease (COPD) (Kreindler et al., 2005; Parker et al., 2010; Adamson 
et al., 2011). The developed asthma models include an epithelial layer exposed to antigens 
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or treated with the cytokines interleukin 4 (IL-4) and IL-13, which both play a vital role in 
asthma (Kanoh et al., 2011; Parker et al., 2013). Other studies have used cigarette smoke 
extract to evaluate the effect of cigarette smoking on the mucociliary function of the airway 
epithelium (Kreindler et al., 2005).  
 
1.2.2 In Vitro Female Reproductive Tissue Models 
In vitro models of female reproductive system-specific cells, tissues and organs for clinical 
application were of interest as the early goal of this research was to investigate tissue 
engineering approaches for developing an in vitro human oviduct mucosa. Several studies 
have investigated the possibilities of engineering female reproductive tissues such as 
functional uterine tissue using autologous cells, reconstructing three-dimensional (3D) 
cervical tissue and engineering vaginal tissue in vivo (Campbell et al., 2008; House et al., 
2010; Atala, 2012). Oviduct tissue engineering studies are limited, and lately, investigators 
have focused on the human oviduct, as it contains mesenchymal stem cells (Jazedje et al., 
2009). These cells have great potential of differentiating into muscle, fat, bone and cartilage 
cell lineages. Miessen et al. (2011) regenerated the epithelium in porcine oviducts. After 
culturing epithelial cells from pig oviduct in vitro for 3 weeks, they confirmed the formation 
of epithelium composed of ciliated and secretory cells (Miessen et al., 2011). Atala et al. 
(2012) examined the possibility of engineering functional uterine tissue using autologous 
rabbit smooth muscle cells and epithelial cells (Atala, 2012). The cells were seeded on 
uterus-shaped biodegradable polymer scaffolds. These were hereafter used to replace 
subtotal uterine tissue in autologous rabbit uterus. The engineered uterine tissue was 
inspected and analysed 6 months after implantation to confirm the presence of normal 
uterine tissue constituents. Biomechanical testing showed that the functional characteristics 
of the implanted tissues were comparable with that of normal uterine tissue. Campbell et al. 
(2008) also performed an animal study on uterine regeneration using the peritoneal cavity of 
rats and rabbits as in vivo bioreactors to construct a uterine tissue graft (Campbell et al., 
2008). The graft was regenerated by implanting biomaterial templates, which were removed 
after 2–3 weeks. Twelve weeks after grafting, the uterine tissue graft showed increased 
thickness and the same morphology as a normal uterus. Engineered uterine tissue influenced 
the present project greatly, especially the tissue layers and cell types, as these are to some 
extent comparable to those found in the oviduct.  
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1.3 Cell-Protein-Biomaterial Interactions 
1.3.1 Biomaterials  
According to the current definition of the European Society of Biomaterials (ESB), 
biomaterials are materials that can interact with biological systems to evaluate, treat, 
augment or replace tissues or body parts. They can also be used for delivering drugs or 
biological elements (Bose e Bandyopadhyay, 2013). Thus, it is crucial that a material is 
biocompatible to be characterised as a biomaterial (Nair e Laurencin, 2007). Biomaterials 
are classified according to their crystallinity, bonding and structure. Due to their high elastic 
modulus and strength and presence of strong metallic bonds between tightly packed atoms, 
metals have been the longest-used biomaterial in many load-bearing applications. However, 
metals can cause corrosion and therefore need to be treated through passivation to be used 
as a biomaterial. Solid, non-conducting materials bonded through ionic and/or covalent 
bonds are known as ceramics and are often used in orthopaedic and dental applications, heart 
valves and many other medical applications. Polymers are characterised by their long carbon 
chains bound together by covalent bonds and are non-conducting materials. They can be 
crystalline, amorphous or both, and have low elastic modulus and strength and are ductile. 
Polymers have been widely used as biomaterials for the past 50 years, especially in tissue 
engineering and in the present research (Bose e Bandyopadhyay, 2013; Agrawal et al., 
2014a).  
 
1.3.2 Poly-L-Lactic Acid  
Poly (lactic acid) (PLA) is a biodegradable thermoplastic polyester derived from renewable 
resources such as corn, wheat or rice that can be produced from lactic acid (Agrawal et al., 
2014b). The discovery of PLA originated Bischoff and Walden’s lactide production formula 
in 1893, which led to the first production of PLA by Carothers in 1931 (Rasal et al., 2010). 
In the early 1970’s, the US Food and Drug Administration (FDA) approved the use of PLA 
for food and pharmaceutical applications (Xiao et al., 2011). Over the last several decades, 
PLA has been extensively investigated and used in medical applications, including sutures 
and orthopaedics bone fixation tools and implants, and has been widely used for tissue 
engineering applications and drug delivery systems (Rasal et al., 2010). PLA can be 
synthesised through polycondensation of lactic acid monomers or through ring-opening 
polymerisation (Xiao et al., 2011). PLA is typically synthesised in the presence of both D- 
and L-lactic acid isomers, which can produce two variants of PLA: poly-D-lactic acid 
(PDLA), a crystalline material, and poly-L-lactic acid (PLLA), which is less crystalline. The 
 19 
degradation ratio, toughness, glass transition and melting temperature all vary with the ratio 
of these isomers in the PLA materials (Table 1.2).  
 
Table 1.2. PDLA and PLLA properties. 
Properties PDLA PLLA 
Crystalline structure  Crystalline Hemicrystalline  
Melting temperature (Tm) 180C 180C 
Glass transition temperature 
(Tg) 
50-60C 55-60C 
Elongation at break  20-30% 20-30% 
Half-life in 37C normal 
saline 
4-6 months 4-6 months 
 
 
Apart from its biodegradability, the main advantages of PLA are its biocompatibility and 
processability. In the biomedical field, biocompatible materials are required for many 
applications that come in direct contact with living tissues or cells and should therefore not 
yield toxic or carcinogenic reactions when applied (Lanza et al., 2011). Upon contact with 
water, PLA is degraded through hydrolysis of the ester bond. When in contact with a living 
organism, such as the body, it degrades and its soluble degradation product, lactic acid, 
enters the tricarboxylic acid cycle, and then is excreted. This makes PLA attractive for 
several biomedical applications, including tissue engineered models. Furthermore, the 
thermoplastic properties of PLA make it possible to reshape and is often easily processed by 
injection moulding, film extrusion and fibre spinning when compared to other polymers such 
as polycaprolactone (PCL) and polyethylene glycol (PEG) (Rasal et al., 2010; Elsawy et al., 
2017).  
Some of the limitations of PLA include slow degradation, hydrophobicity and poor 
toughness, which in return renders it less appropriate for biomedical usage. Pure PLA 
induces a mild inflammatory response when in contact with living tissue and low affinity 
with cells when used in tissue engineering materials. Several surface modification 
techniques, such as surface coating, biomacromolecule entrapment and plasma treatment, 
have been investigated to eliminate these drawbacks. Surface coating is the simplest 
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modification technique, involving the adsorption of molecules, such as ECM proteins and 
arginine–glycine–aspartic acid (RGD) peptides, on the polymer surface. These surface 
coatings enhance the polymer–cell interaction by aiding cell adhesion, thus increasing the 
biocompatibility of PLA (Eid et al., 2001). 
  
1.3.3 Cell-Material Interactions 
Cell adhesion is a crucial early step in cell culture and plays a key role in determining cell 
fate (Gumbiner, 1996; Salmeron-Sanchez e Altankov, 2010). Cells lack the ability to directly 
interact with synthetic materials but can recognise and attach to adsorbed ECM proteins on 
materials through integrins. Integrins are transmembrane receptors comprised of two non-
covalently bound subunits,  and , which form heterodimers and are pivotal in cell–ECM 
adhesion. Depending on the subunit combination, integrins can bind the actin cytoskeleton 
to the ECM proteins through extracellular binding adhesion sites such as the RGD motif, 
which is found in various ECM proteins, including fibronectin (FN) and vitronectin (VN) 
(Hynes, 2002; García, 2005). Once cell–ECM ligand binding occurs, the integrins cluster 
and recruit other cytoplasmic proteins to form focal adhesions (FAs), supramolecular 
complexes consisting of structural proteins, including vinculin, paxillin or talin, and 
signalling molecules (Figure 1.6). Combined with growth factor receptors, FAs activate 
various signalling pathways that regulate gene expression and protein activity that control 
cell proliferation, motility, cytoskeleton reorganization and differentiation. β1 Integrins are 
involved in extracellular binding adhesions of several connective, muscular and epithelial 
cells, including adsorbed ECM proteins on materials. Mediated by integrins through ECM 
adhesion binding, cell–protein–material interaction can occur through: 1) protein adsorption 
from, for example, blood, plasma or serum adsorbed on the material surface; 2) proteins 
secreted by cells onto material surfaces; and/or 3) by applying engineered adhesion motifs 
such as the RGD motif (Garcia, 2006). Although cells adhere to material surfaces 
functionalized with ECM proteins, many of them degrade and reorganise the adsorbed 
protein layer and secrete their own ECM proteins.  
 21 
 
 
 
Figure 1.6 An overview of cell–matrix adhesion and FA complexes. Figure adapted Berrier 
et al.  (Berrier e Yamada, 2007).   
 
1.3.4 Protein Adsorption 
Protein adsorption on material surfaces occurs due to energetic interactions, such as 
hydrogen-bonding, electrostatic or van der Waals interactions, between the molecular 
groups of the material and the protein (Salmeron-Sanchez e Altankov, 2010).  Protein 
concentration, rate diffusion and affinity influence the protein–material interaction (Schmidt 
et al., 2009). A higher protein concentration means that more proteins will be adsorbed on 
the material. The diffusion rate regulates the protein movement in solution and is affected 
by the protein size. Smaller proteins are faster and adsorb onto the material more quickly 
compared to larger and bulkier proteins. The likelihood of protein adsorption to material 
surfaces is known as the affinity of the protein and depends on properties of both the protein 
and the material. However, larger proteins have more binding sites, thus higher affinity, and 
replace proteins pre-adsorbed on the material. Proteins with high affinity interact with the 
surface of a material by forming numerous strong bonds that adhere to the surface and are 
more likely to be adsorbed. Other proteins can replace the adsorbed protein over time as 
bonds between the adsorbed protein and the material are broken or due to the presence of 
proteins with higher affinity on the surface, a process known as the Vroman effect. The 
hydrophobicity or hydrophilicity of a protein influences the interaction with the material, as 
nonpolar domains of the protein bind to the nonpolar domains of the material while avoiding 
its polar domains, and vice versa (Garcia, 2006; Schmidt et al., 2009). In this project, three 
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proteins: FN, Col IV, and LM, will be used as intermediate proteins between cells and 
material surfaces to determine the protein that promotes cell attachment. 
 
Fibronectin  
FN is a high–molecular weight glycoprotein with domains that bind to ECM components 
and to cell surface receptors (Pankov e Yamada, 2002; Salmeron-Sanchez e Altankov, 
2010). These bindings promote cell–matrix adhesion and various other cell–ECM 
interactions such as cell migration, growth and differentiation. There are three types of FN: 
1) matrix, 2) cell surface, and 3) plasma. Matrix FN is an adhesive glycoprotein found in the 
ECM as fibrils. Cell surface FN attaches briefly to cell surface receptors, while plasma FN 
is a circulating plasma protein found in the blood and plays a key role in blood clotting, 
wound healing and phagocytosis (Magnusson e Mosher, 1998). Studies have shown the 
importance of FN in epithelial cell proliferation and survival by reducing the apoptosis rate 
when coated onto surfaces (De Jong-Hesse et al., 2005; Han e Roman, 2006). FN consists 
of three domains: FNI, FNII and FNIII, that bind to ECM and cells and to other FNs (Figure 
1.7) (Pankov e Yamada, 2002). Cell adhesion occurs at FNIII10, known as the RGD 
sequence, and at the synergy site at FNIII9 via 51 integrin binding (Vanterpool et al., 
2014).  
 
 
Figure 1.7. An overview of FN structure when extended showing the FNI, FNII and FNIII 
domains. The regions involved in cell adhesion, i.e. FNIII9 (synergy site) and FNIII10 (RGD 
sequence) are highlighted.   
 
Type IV Collagen 
As it has a non-collagenous (NC) domain, Col IV is a non-fibrillar collagen and therefore 
differs from other fibrillar collagens that can be found in the connective tissue. There are six 
distinct Col IV chains known as α-chains (α1–α6), which are encoded by six different genes. 
Epithelial cells secrete Col IV as protomers of three α-chains through their Golgi apparatus. 
 23 
Each chain is approximately 400-nm long and it is composed of the following (Figure 1.8) 
(Lebleu et al., 2007; Lebleu et al., 2010): 
• An N-terminal 7S domain, which is essential for Col IV network formation. This 
domain is 26 kDa and is 28-nm long, 
• A triple helical domain that contains a repetitive Gly-X-Y amino acid sequence; it is 
120 kDa and roughly 320-nm long, and  
• A C-terminal NC globular domain known as the NC1 domain. This domain is also 
critical for Col IV network formation and is approximately 25 kDa and 52-nm long. 
The NC1 domain restricts the association of each α-chain by limiting random α-chain 
binding, thus giving rise to the different protomers secreted by epithelial cells in vivo. 
  
 
 
Figure 1.8. The Col IV protomer is made of three  chains and consists three domains of 
Col IV: the N-terminal 7S domains, a collagenous repetitive Gly-X-Y amino acid sequence 
known as the triple helical collagenous domain, and a C-terminal NC globular domain 
known as the NC domain. Figure adapted from LeBleu et al.  (Lebleu et al., 2007). 
 
Laminin 
The LM protein family consists of 11 chains (α1–5, β1–3, γ1–3), where each chain is formed 
as an α-, β-, and γ-chain in a ‘three-pronged fork’ structure with a length of 160 nm and an 
approximate molecular weight of 400 kDa (Figure 1.9) (Aumailley e Smyth, 1998; Lebleu 
et al., 2007).  The β-chain is 200 kDa and forms a 60-nm long short arm that binds collagen 
and cells; the γ-chain forms the shorter arm (40 nm) and is the binding site for entactin. The 
‘handle’ of the LM fork is around 77-nm long and consists only of the α-chain at the end, 
and is known as the C-terminal G domain. This domain consists of five homologous globular 
motifs (LG domains), which are the major sites for cell adhesion, as integrins bind to LM at 
this region. Fifteen types of LM chain compositions have been characterised and detected in 
the basal lamina (Lebleu et al., 2007).  
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Figure 1.9. LM is heterotrimer which is composed by an α-, β-, and γ-chain in a ‘three-
pronged fork’ structure. Figure adapted from LeBleu et al. (Lebleu et al., 2007).  
 
1.4 Culture Dimensionality  
Two-dimensional (2D) culture systems often include a cell monolayer cultured on flat and 
rigid materials, and have been widely used for various cell and molecular biology studies 
since they were first developed by Harris et al. (1907) in 1907 (Harrison, 1907; Edmondson 
et al., 2014). Such 2D culture techniques have been imperative for understanding cell 
physiology and responses to various drugs, compounds, material surfaces and external 
stimuli. Nevertheless, these systems lack the capability to mimic the in vivo environment, 
which consists of a 3D environment of cells and ECM (Edmondson et al., 2014; Shamir e 
Ewald, 2014). Cells are often surrounded by other cells and can reside within the ECM, such 
as in the case of fibroblasts and chondrocytes, or rest on a basal ECM, such as epithelial cells 
and their underlying basement membrane (Rhee, 2009). However, cells in 2D cultures 
exhibit a flat morphology due to cell adhesion being limited to the horizontal plane and not 
in the z-plane, as well as dedifferentiation. The flat morphology forces the cells to grow in 
an apical–basal polarised environment that often is not natural for the cells and can cause 
changes in cellular behaviour and affect cell fate. Cells in a 3D environment expose several 
integrin-binding sites that bind to the ECM as compared to conventional 2D culture models, 
where the cells adhere through FA. As mentioned earlier, integrins activate various 
signalling pathways that in turn play a key role in cell fate and cell responses. Thus, 3D cell 
culture models, different from 2D culture systems, provide a more precise representation of 
the in vivo microenvironment and cellular behaviour due to the morphological and 
physiological behaviour of the cells presenting a more accurate in vivo–like cell response. 
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1.4.1 Air-Liquid Interface Culture 
Cell culture conditions play a vital role in the morphology and function of epithelial cells 
cultured in vitro (Nossol et al., 2011). These conditions include the choice of using primary 
cells versus tumour-derived cell lines, cell culture substrates, culture medium and 
supplements, and cell culture setups (Dimova et al., 2005). Primary cells are obtained 
directly from organ tissues and cultured, and represent the in vivo morphology more closely 
than cell lines, and are standard cells for pharmatoxicological studies and are correlated with 
clinical conclusions. However, unlike cell lines, primary cells are subject to the limitations 
of availability from donor tissue, low cell number and heterogeneity within cultures (Dimova 
et al., 2005; Cree et al., 2010). Due to their rapid growth, homogeneity and ability to 
reproduce consistent results, cell lines have been widely used for epithelium airway and 
cancer research (Cree et al., 2010; Schmidt et al., 2017). Traditionally, in vitro culture 
systems for the epithelial layer involve epithelial cells cultured on flat, non-porous 2D 
substrates, and unlike the in vivo environment, these culture systems provide nutrients to the 
epithelial cells via their apical and basolateral surfaces instead of the basal side. These 
substrates include plastic tissue culture dishes, glass and plastic coverslips, inorganic porous 
membranes with or without protein coatings, and hydrogels. As such cell culture substrates 
influence the cellular phenotypic responses, epithelial cells grown on plastic culture tissue 
dishes have flat and squamous morphology with poor ciliation and secretory cells. Thus, 
there is a need for an improved in vitro model that not only mimics the in vivo environment 
of the epithelium but also supports cell differentiation on the apical surface and maintains 
cell polarity. In the 1980’s, Whitcutt et al. (1988) developed an in vitro model to mimic the 
in vivo environment of the epithelial layer by introducing an ALI-based culture system of 
respiratory tract epithelium using a permeable gelatine membrane (Whitcutt et al., 1988). 
The ALI system provided nutrients to the epithelial cells through their basal surface while 
exposing the cells to air on their apical and basolateral sides, providing the epithelial layer 
with oxygen. With this study, the authors could confirm that an ALI culture system improved 
epithelial differentiation and maintained epithelial cell polarity. As mentioned previously, 
the epithelium is a polarised layer of epithelial cells where the apical side is constantly 
exposed to gases, and acts as a protective layer along with an underlying basement 
membrane and loose connective tissue, preventing external microorganisms, pathogens and 
antigens from entering the body. ALI culture systems mimic the in vivo environment by 
providing cells with constant exposure to gases, mainly improved oxygen supply; this differs 
from in vitro culture, where cells are cultured on substrates and submerged in feeding culture 
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medium in which gas molecules are poorly soluble (Dimova et al., 2005; Aoki et al., 2016). 
Since Whitcutt et al. (1988) , several other researchers have provided growing evidence that 
ALI cultures promote epithelial cell proliferation, differentiation and polarity as well as 
enable in vivo–like morphology (Lin et al., 2007; Yee et al., 2010; Nossol et al., 2011; 
O'boyle et al., 2018). Some examples of epithelial cells cultured in ALI systems include: 1) 
normal human bronchial epithelial cells (NHBEs) with a well-differentiated epithelium 
consisting of pseudostratified columnar cells with cilia and tight junctions (Chan et al., 
2010), and 2) intestinal porcine epithelial cells (IPECs) with an in vitro epithelial layer with 
great morphological resemblance to intestinal epithelium in vivo (Nossol et al., 2011).  
 
In the present project, an ALI culture technique will be used to create an in vitro bronchial 
mucosa consisting of human bronchial epithelial cells (HBEpiCs) and human telomerase 
reverse transcriptase (hTERT) dermal fibroblasts cultured on the apical and basal side, 
respectively, of electrospun PLLA membranes. The membranes will be coated with ECM 
proteins such as FN. In addition, the project will investigate the possibilities of converting 
the bronchial mucosa model into an in vitro asthma model. This will be done by introducing 
IL-13 to the cells, as IL-13 plays a key role in asthma.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 27 
2. Research Objectives  
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2.1 Research Objectives 
This research project aims to establish a novel in vitro mucosa model consisting of well-
differentiated epithelial cells and an underlying loose connective tissue containing mainly 
fibroblasts. The tissue engineering approaches that will be used include developing a porous 
biodegradable polymer membrane via electrospinning, functionalising the membrane with 
the ECM proteins FN, Col IV and LM, and using the ALI culture system to enable epithelial 
cell differentiation and support epithelial cell polarity. The main mucosal tissue of interest 
is the bronchial mucosa containing HBEpiCs and fibroblasts. In addition, the project will 
investigate the possibility of converting the in vitro bronchial mucosa tissue to a disease 
model, such as asthmatic tissue, to explore the application potentials of the model for disease 
and treatment studies. 
 
The main objectives in this PhD thesis are: 
• To design and manufacture a thin membrane-like PLLA scaffold resembling the native 
ECM of the mucosa in both structure and function. A porous scaffold with a high surface 
area to volume ratio is required to enhance cell adhesion and differentiation and the 
diffusion of nutrients and waste products. 
• To develop a consistent and robust co-culture system composed of cells, extracellular 
proteins, and porous biodegradable PLLA. This culture system should be ideal for long-
term cell culture and to support and maintain the in vivo–like morphology of a lamina 
propria and an epithelium in vitro. 
• To study the cell behaviour, such as adhesion, differentiation, and morphology, of the in 
vitro–cultured mucosae. 
This project involves a high degree of interdisciplinary interaction, combining engineering, 
biology, chemistry and medical science. A novel model that utilises synthetic biology and 
biomaterials to reconstruct mucosae in vitro by using an ALI culture system that supports 
the differentiation, growth and morphology of cells found in the mucosa, is presented. The 
approaches utilised in this work can be extended to the regeneration of several mucosal 
tissues that line the lumen of several organs and skin tissue. However, the main focus will 
be on bronchial mucosae. To successfully proceed with the project, a multidisciplinary and 
international collaboration between the University of Glasgow, the Skive Fertility Clinic 
(Region Midt) and Faculty of Health, Aarhus University, has been established. 
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Research Question 
Is it possible to engineer in vitro mucosa with in vivo–like morphology and function, 
combining biomaterials, proteins and cell co-culture in a system that can be used as a 
platform for future in vitro applications of the bronchial mucosae? 
 
Hypothesis 
By coating PLLA thin scaffolds with ECM proteins in an ALI culture system, it will be 
possible to develop a functional in vitro mucosa featuring lamina propria and a polarised 
epithelium, characteristic of tissues with in vivo–like morphology. 
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3. Materials and Methods 
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3.1 Spin Coating  
Spin coating is often used to produce thin polymer films and involves applying centrifugal 
forces at a constant speed to spread a polymer solution onto substrates, thereby creating 
uniform polymer films. The film thickness can be regulated by controlling several solution 
properties, such as viscosity and surface tension, and by controlling the substrate surface 
properties. Other parameters that affect film thickness include the rotational speed, 
acceleration and the duration of the spin coating. PLLA films were prepared using spin 
coating (Agrawal et al., 2014).  
 
Poly (ethyl acrylate) (PEA) polymers, initiated by 0.35% wt benzoin, were dissolved in 2.5% 
cilia/v toluene; the PLLA polymers (Goodfellow, Huntingdon, UK) were dissolved in 2% 
cilia/v chloroform (Sigma-Aldrich, St. Louis, MO, USA). Both PEA and PLLA samples 
were thereafter spin-coated onto 12-mm round glass coverslips for 30 seconds at 2000 rpm 
and for 5 seconds at 3000 rpm, respectively, with acceleration of 3000 rpm/sec. The PEA 
coverslips were heated at 60°C for 1 hour, and both PEA and PLLA were placed under a 
vacuum for 2 hours to remove excessive dissolvent. 
 
3.2 Electrospinning  
Electrospun PLLA 
Two PLLA solutions were prepared by dissolving the polymer in chloroform and in 
hexafluoro-2-propanol (HFIP; >99% pure, Sigma-Aldrich), respectively. The polymer 
solutions were electrospun for 10 minutes onto a collector covered with aluminium foil at a 
constant flow rate of 0.9 mL/cilia using a 1-mL syringe and a needle with an internal 
diameter of 0.15 mm. The concentration applied voltage and gap distance between the needle 
and the collector were selected as the variable parameters (Table 3.1 and Table 3.2).   
The temperature was kept at 20.5C ± 0.5C throughout the entire experiment. Once the 
PLLA membranes were electrospun, they were vacuum-dried at 60°C for 24 hours to remove 
excessive dissolvent. All membranes were cut into 2 × 2 cm squares and mounted on 
CellCrown 24-well plate cell culture inserts (Scaffdex Oy, Tampere, Finland) and sterilised 
in 70% ethanol, followed by 1-hour ultraviolet (UV) sterilisation in a sterile culture hood. 
 
 
 
 32 
Table 3.1. Electrospinning parameters for PLLA solution dissolved in chloroform. 
 
 
Table 3.2. Electrospinning parameters for PLLA solution dissolved in HFIP. 
 
 
 
 
 
 
 
 
Membrane Solution (% w/v) Gap 
distance 
(cm) 
Voltage 
(kV) 
A1Chlor 8% in Chloroform 12 20 
A2Chlor 8% in  
Chloroform 
15 20 
B1Chlor 8% in  
Chloroform 
10 10 
B2Chlor 10% in  
Chloroform 
12 20 
C1Chlor 10% in  
Chloroform 
12 15 
Membrane Solution (% 
w/v) 
Gap distance 
(cm) 
Voltage 
(kV) 
O 8% in HFIP 12 20 
A1 8% in HFIP 15 20 
A3 8% in HFIP 10 10 
B1 10% in HFIP 12 20 
B5 10% in HFIP 12 15 
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Electrospun Poly Lactic Glycolic Acid (PLGA) 
18 % of poly lactic glycolic acid (PLGA – Sigma-Aldrich) polymers were dissolved in 
hexafluoro-2-propanol (HFIP; >99 % pure, Sigma) and 1% NaCl was added to the polymer 
solution in three different bottles. The polymer solutions were electrospun separately onto a 
collector covered with aluminium foil with an applied voltage of 20 kV, flow rate of 5 mL/h, 
and a distance of 15 cm between the collector and the needle tip. Each sample was 
electrospun for 10 min with a 1 mL syringe and a needle with an internal diameter of 0.25 
mm. Randomly aligned electrospun polymer fibres were collected on the collector. The 
samples were vacuum dried for 16h to remove excessive HFIP and stored in petri dishes 
wrapped in parafilm for 3 days prior to the scanning electron microscopy (SEM). All 
membranes were cut into 2 × 2 cm squares and mounted on CellCrown 24-well plate cell 
culture inserts (Scaffdex Oy) followed by either UV light or 80 % ethanol sterilisation for 1 
h.  
 
3.3 Protein Adsorption 
Col IV, FN and LM were used to study cellular behaviour on protein-coated PLLA surfaces. 
To investigate protein adsorption and conformation, Col IV (20 or 50 μg/mL) from human 
placenta (Advanced Biomatrix, Carlsbad, CA, USA) dissolved in acetic acid, human LM 
(20 μg/mL, Sigma-Aldrich), a Col IV and LM mixture (10 μg/mL of each) and FN (20 
μg/mL, R&D Systems, Minneapolis, MN, USA) were coated on spin-coated PLLA surfaces 
for 10 minutes each at room temperature (RT), followed by nitrogen (N2) air-drying. 
For studies that used FN as an intermediate protein layer between cell–protein–material 
configurations, 20 μg/mL human plasma FN solution (R&D Systems) in Dulbecco’s 
phosphate-buffered saline (DPBS) was used. The protein was coated on UV-sterilised PEA 
and PLLA spin-coated coverslips (200 μL per coverslip) or on electrospun PLLA 
membranes for 1 hour (see Section 3.2, Electrospinning). Spin-coated PLLA surfaces were 
coated with 50 μg/mL Col IV, 20 μg/mL FN, 20 μg/mL LM or 10 μg/mL Col IV plus 10 
μg/mL LM for 1 hour at RT and washed with DPBS. 
 
3.4 Cell Culture  
hTERT dermal fibroblasts (ATCC, VA, US) were resuscitated and resuspended in 
Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, Carlsbad, CA, US) containing 
1% v/v penicillin-streptomycin, 0.05% fungizone and 10% v/v fetal bovine serum (FBS). 
Primary human umbilical vein endothelial cells (HUVECs – Sigma-Aldrich) were 
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resuscitated at passage 4 and resuspended in human large vessel endothelial culture medium 
containing 1% v/v penicillin-streptomycin and 1 mL HUVEC growth supplement 
(Invitrogen). Primary HBEpiCs (ScienCell Research Lab Laboratories, Carlsbad, US) were 
resuscitated at passage 3 and resuspended in bronchial epithelial culture medium (BEpiCM, 
ScienCell Research Laboratories) containing 1% v/v penicillin-streptomycin and 1% 
bronchial epithelial cell growth supplement (BEpiCGS, ScienCell Research Laboratories). 
All cells were incubated at 37°C in 5% CO2 for 3 days and harvested by trypsinization when 
they were 90% confluent. For all FA assays, cells were seeded at a density of 5000 cells/cm2. 
 
3.4.1 Air Liquid Interface Culture 
For HBEpiC cell differentiation studies, HBEpiCs were cultured individually or co-cultured 
with hTERT dermal fibroblasts in ALI or non-ALI culture configuration. For the ALI co-
culture studies, fibroblasts were seeded on the basal side of FN-coated PLLA membranes 
(25 × 103 cells/cm2) with DMEM + 10% FBS and incubated at 37°C in 5% CO2 for 2 days. 
The HBEpiCs were seeded 2 days later on the apical side of the coated membranes and co-
cultured with or without fibroblasts in 50:50 BEpiCM with BEpiCGS and DMEM 
containing 5% FBS for an additional 5 days at 37°C in 5% CO2. The HBEpiCs were seeded 
at a density of 25 × 104 cells/cm2, unless otherwise stated, to optimise the formation of a 
fully confluent epithelial monolayer. The HBEpiCs were raised in ALI by removing the 
culture medium from the apical compartment of the inserts. Once the ALI was established, 
the medium in the basal compartment was changed every 48 hours. The cells were co-
cultured in the ALI system for 2, 4 and 6 weeks for differentiation studies. 
For comparison studies, both HBEpiCs and fibroblasts were co-cultured in ALI for 4 weeks 
on Transwell cell culture inserts containing porous PET membranes. Like the PLLA, these 
membranes were also coated with FN prior to cell seeding. 
 
3.4.2 Asthma Model  
Once the ALI co-culture of HBEpiCs and fibroblasts was established, 20 ng/mL IL-13 
(Sigma-Aldrich) was freshly added to the medium every 48 hours to create an in vitro 
asthma-mimicking mucosa model, which was further cultured for 2 and 4 weeks with a 
medium change every 48 hours. After 2 weeks’ ALI co-culture of the in vitro asthma-
mimicking mucosa model, IL-13 was removed from the medium for airway remodelling and 
mucin hyperproduction studies. For these studies, 1 µg/mL dexamethasone (Sigma-Aldrich) 
was freshly added to the medium every 48 hours with and without the addition of IL-13 
 35 
(Dex+IL-13 and Dex-IL-13, respectively). Both the in vitro asthma-mimicking and 
bronchial mucosa models were used as controls. All samples were cultured for an additional 
2 weeks in ALI with medium change every 48 hours. 
  
3.5 Immunostaining  
3.5.1 Focal Adhesions and Cell Morphology 
Samples were fixed with 3.7% v/v formaldehyde in a fume hood for 20 minutes at RT and 
washed with DPBS. For the FA assay, the samples were incubated with anti-vinculin 
antibody (1:400 dilution, Sigma-Aldrich) for 1 hour at RT and washed three times with 
DPBS/Tween-20 (0.5% v/v). The samples were thereafter incubated with Cy3 rabbit anti-
mouse secondary antibody (1:100 dilution, Jackson ImmunoResearch, West Grove, PA, 
USA) in the dark for 1 hour at RT. The FA assay and morphology assay samples were all 
incubated with 200 μL BODIPY FL phallacidin (1:100 dilution, Invitrogen) for 20 minutes 
at RT before being mounted with Vectashield with 4′ 6‐diamidino‐2‐phenylindole (DAPI, 
Vector Laboratories, Inc., Burlingame, CA, USA) to stain the nuclei. 
 
3.5.2 Protein Secretion 
Fibroblasts and HBEpiCs were cultured separately or co-cultured and submerged in culture 
medium, as previously described, on FN-coated PLLA membranes for 7 days. The medium 
was changed every 48 hours. Both cell types were stained for Col IV and LM using 
monoclonal mouse anti-collagen 4α2 (ColIVα2) antibody (1:300, EMD Millipore, Billerica, 
MA, USA) and polyclonal rabbit anti-laminin antibody (1:200, Sigma-Aldrich). Alexa Fluor 
488 goat anti-mouse antibody (1:100, Invitrogen) and Cy3 goat anti-rabbit antibody (1:100, 
Jackson ImmunoResearch) were used as secondary antibodies with 1-hour incubation in the 
dark at RT. All samples were mounted with Vectashield with DAPI to stain the nuclei. 
Confocal fluorescence microscopy (Zeiss LSM 880, Jena, Germany) was used for z-stack 
imaging of Col IV and LM secretion by both cell types. 
 
3.5.3 ALI Culture 
For in vitro bronchial mucosa cultures, the samples were permeabilised with 0.1% v/v Triton 
X-100 for 10 minutes after being fixed and washed and blocked with blocking buffer [1% 
bovine serum albumin (BSA) in DPBS] for 30 minutes. Mouse anti–E-cadherin antibody 
(1:200 dilution) was applied to stain the HBEpiCs on the apical side of the membrane; rabbit 
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anti-S100A4 antibody (1:200 dilution) was used to stain for fibroblast-specific protein 
(S100A4) on the basal side of the membrane. Both primary antibodies were incubated for 1 
hour at RT and washed three times with DPBS/Tween-20 (0.5% v/v). Alexa Fluor 488 goat 
anti-mouse antibody (1:200 dilution) was used as a secondary antibody for the HBEpiCs; 
Cy3 goat anti-rabbit secondary antibody (1:100 dilution) was used for the hTERT dermal 
fibroblasts, with 1-hour incubation in the dark at RT. All samples were mounted with 
Vectashield with DAPI to stain the nuclei using two thin coverslips to enable viewing of 
both sides of the membrane under an epifluorescence microscope. An epifluorescence 
microscope (Zeiss AXIO Observer Z1) was used for imaging the samples; confocal 
fluorescence microscopy was used to characterise cell behaviour on FN-coated PLLA 
membranes when co-cultured in submerged BEpiCM. 
 
3.6 Enzyme-Linked Immunosorbent Assay 
3.6.1 Mucus Secretion 
Mucus secretion was measured by enzyme-linked immunosorbent assay (ELISA). Secreted 
mucus was removed from the HBEpiC apical layer by washing with 50 L DPBS at week 2 
and 4 of the ALI co-culture. Cell lysates were prepared using 100 L 
radioimmunoprecipitation assay (RIPA, R&D Systems) buffer on each ALI culture sample, 
and these were added to the collected mucus. The total secreted mucus was stored at -80C 
for ELISA at a later time. Mucus samples were thawed and diluted in bicarbonate/carbonate 
coating buffer (1:1, Sigma-Aldrich) and incubated in 96-well plates overnight at 37°C. The 
samples were washed three times in DPBS and blocked with 2% BSA for 1 hour at RT. After 
a second wash with DPBS, the samples were incubated with 100 L rabbit monoclonal 
MUC5AC antibody (1:100) diluted with DPBS and 0.05% Tween-20 at RT for 1 hour. The 
samples were washed again before 100 L horseradish peroxidase–goat anti-mouse 
immunoglobulin G (IgG) conjugate (1:10,000, Abcam, Cambridge, UK) was dispensed into 
each well and incubated for 1 hour. The wells were washed three times with DPBS, followed 
by colour reaction development with 3,3′,5,5′-tetramethylbenzidine (TMB) peroxidase 
solution (R&D Systems) and stopped with 1 M H2SO4. The absorbance was read at 450 nm 
with a reference wavelength of 540 nm. 
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3.7 Scanning Electron Microscopy 
3.7.1 PLLA Membrane Characterisation 
The electrospun PLLA membranes were cut into small squares and attached either flat to a 
scanning electron microscopy (SEM) holder to determine the fibre diameter and pore size or 
vertically to determine the membrane thickness. The samples were coated with 
gold/palladium using a POLARON SC515 SEM COATER and visualised with SEM 
running at 10 kV. Three SEM images were captured from each sample for fibre morphology 
studies and to determine the fibre diameter, pore size and membrane thickness. The software 
programme ImageJ (1.47v) was used to measure the membrane thickness and the fibre 
diameters and pore sizes of 10 fibres from each SEM image. Each pore was defined as a gap 
between electrospun fibres within the same focal plane; the longest distance in each pore 
was used to calculate the pore size. 
 
3.7.2 Cell Morphology Assays  
SEM (JEOL6400 SEM, JEOL, Tokyo, Japan) was used to analyse the cell morphology and 
growth. Samples seeded with cells were fixed in 1.5% glutaraldehyde/0.1 M sodium 
cacodylate buffer for 1 hour at 4°C. After fixation, the samples were washed in 0.1 M sodium 
cacodylate buffer rinse three times at 5 minutes per wash before 1-hour incubation in 1% 
osmium tetroxide/0.1 M sodium cacodylate buffer at RT. The samples were washed three 
times with distilled water and stained with 0.5% uranyl acetate/distilled water for 1 hour in 
the dark. The samples were washed again with distilled water before dehydration in an 
ethanol gradient (30%, 50%, 70%, 90% for 10 minutes each) followed by 100% ethanol 
dehydration four times at 5 minutes per dehydration to fully dry the sample. For drying, the 
samples were immersed in hexamethyldisiloxane (HSMO) overnight, and coated with 
gold/palladium using a POLARON SC515 SEM COATER. The coated samples were 
viewed and analysed under SEM running at 10 kV. 
 
3.8 Histology 
Histology assays were performed by the School of Veterinary Medicine, University of 
Glasgow. Cell culture samples were fixed in formaldehyde, and paraffin-embedded sections 
were stained with Gill’s haematoxylin. The sections were washed with distilled water and 
differentiated in 1% acid alcohol. For blueing of the sections, Scott’s tap water was applied, 
followed by eosin staining. The sections were then dehydrated, cleared and mounted. 
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3.9 Image Analysis 
3.9.1 PLLA Fibre Characterisation 
ImageJ was used to analyse and measure the fibre diameters of 10 fibres from each SEM 
image, yielding a total of 30 fibres per sample. Each pore was defined as a gap between the 
electrospun fibres within the same focal plane, and the longest distance in each pore was 
used for measuring the pore size. Ten pore sizes were measured from each SEM image and 
a total of 30 pores were measured for each sample. 
 
3.9.2 FA Assay and Cell Morphology 
Epifluorescence microscopy images were taken using ImageJ, and the different channels for 
localising nuclei, actin and FAs were merged. A web-based FA analysis server [Focal 
Adhesion Analysis Server (FAAS)] was used to calculate and analyse FA numbers by 
obtaining data such as FA area and length. 
 
3.9.3 High-Speed Recording of Motile Cilia 
A video of beating cilia was recorded using a Photron Ultrafast camera mounted on a Zeiss 
microscope by capturing 1000 frames per second (fps) with 1/1250-second shutter speed 
(1250 images per second). The video playback speed was 125 fps (10× slower than live). 
The width of the whole video was 50 m. 
 
3.10 Atomic Force Microscopy 
Atomic force microscopy (AFM, JPK Instruments, Berlin, Germany) was used to 
characterise the conformation of Col IV, FN and LM on the spin-coated PLLA surfaces. The 
different surface heights were used to indicate how much protein was adsorbed on the spin-
coated PLLA samples and to determine the protein conformation on the polymer surfaces. 
 
3.11 Water Contact Angle 
The hydrophobicity of FN- and non–FN-coated PLLA membranes was quantified by 
measuring the static water contact angle using a 3-μL drop of deionised water onto the 
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membranes. The measurements were obtained using a Theta Optical Tensiometer (Biolin 
Scientific, Stockholm, Sweden). 
 
3.12 Degradation Assay of PLLA and PLGA Membranes 
The PLLA membranes were cut into 2.5 × 2.5 cm squares and washed in distilled water, 
followed by 24-hour vacuum-drying at RT. The membranes were weighed prior to being 
placed in a 24-well with DMEM containing 1% v/v penicillin-streptomycin (Sigma-Aldrich) 
and 0.05% fungizone for the degradation assay. The medium was changed every 48 hours. 
The samples were washed in distilled water, vacuum-dried for 24 hours and weighed again 
at week 2, 4 and 6. 
After sterilisation with either UV light or 80 % ethanol sterilisation for 1 h, the PLGA 
membranes were kept in 50:50 DMEM with 10% FBS and 0.05% Fungizon and Bronchial 
epithelial cell medium (BEpiCM with 1% bronchial epithelial cell growth supplement 
(BEpiCGS)) and 1% v/v penicillin-streptomycin over 4 days. The medium was changed 
every 48 hours. 
 
3.13 Statistical Analysis 
A statistically significant number of repetitions was performed for each measurement to 
ensure high repeatability in all experiments. Each measurement was repeated at least three 
times on the same sample batches under the same conditions to quantify the reliability of the 
obtained data. The standard deviation (SD) of the differences between two measurements on 
the same sample were calculated as follows: 
√2 × within subject SD. 
A sample size with a minimum of three samples was used for the in vitro experiments. 
Statistical analysis performed using analysis of variance (ANOVA) and Student’s t-test. 
Differences between measurements was considered significant for p < 0.05, and SDs are 
presented as error bars. 
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4. Engineered Membranes for 
Supporting Cell Co-Cultures 
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This chapter will introduce the development of a porous biodegradable PLLA membrane 
functionalised with ECM proteins to optimise cell–material interaction and cell adhesion. 
The proteins that will be used are FN, Col IV and LM. The chapter will look at the 
conformation of these proteins on PLLA surfaces and thereafter study the cellular behaviour 
of three cell types, i.e. HBEpiCs, HUVECs, and hTERT dermal fibroblasts. Cell attachment 
of the three cell types will be evaluated by examining the FAs and cell morphology. 
Furthermore, the chapter explores means of optimising epithelial cell and fibroblast growth 
on PLLA membranes in an ALI culture setup as a first step towards engineering in vitro 
bronchial mucosa. 
 
4.1 Nanofibre PLLA Membranes 
When designing a scaffold, the ultimate goal is to develop a structure that can mimic the 
natural ECM of the host, and with time, eventually replace it. Besides its physiological 
function, the natural ECM also serves as a scaffold after injury to support and enhance tissue 
repair. It provides mechanical support and regulates cell activities, such as phenotype, 
development and functions (Metcalfe e Ferguson, 2007; Kamel et al., 2013). The main 
functions of a scaffold are to: 1) promote interaction between the biomaterial and the cells, 
enhance cell adhesion and replace the natural ECM, 2) allow the transportation of nutrients, 
gases and regulatory elements to increase cell survival, proliferation and differentiation, 3) 
degrade matrices as tissue regenerates in cell culture, and 4) minimise inflammation and 
toxicity. Scaffolds can be derived from naturally occurring materials, such as collagen, 
alignate, chitosan, hyaluronan and FN. These materials can be used alone or in combination. 
The advantages of natural scaffolds are low toxicity and low inflammatory response upon 
implantation, and they are widely used in the clinic. On the other hand, the characteristics of 
synthetic scaffolds, such as strength, controllable degradation rate, porosity and the ability 
to change shape and size, are also highly desired and highly reproducible (Dhandayuthapani 
et al., 2011; Lanza et al., 2011). However, one disadvantage of synthetic scaffolds is the 
absence of cell recognition signals. Previous studies have shown that a hybrid scaffold 
consisting of a biodegradable polymer and ECM proteins optimises not only the 
biomechanical properties but also cell attachment and migration (Mcpherson e Badylak, 
1998). The requirements of biomaterial scaffolds used for tissue engineering include a 3D 
scaffold structure, biocompatibility, and in most cases, biodegradability with a suitable 
degradation rate. The mechanical strength, porosity, degradation rates, surface chemistry 
and incorporation of biologically active molecules all affect the characteristics of the 
scaffold (Subia et al., 2010). When designing a polymeric scaffold, three main factors should 
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be taken into account: 1) The scaffold architecture, 2) Cell adhesion ligands, and 3) Matrix 
elasticity, as these factors control cell fate. Scaffold fabrication techniques affect the scaffold 
properties and functions; hence, the fabrication method should be chosen carefully. 
Polymeric scaffolds can be manufactured via several scaffold fabrication techniques, 
including fibre bonding, solvent casting and particulate leaching, spin coating, and 
electrospinning (Subia et al., 2010; Lanza et al., 2011).  
 
Electrostatic fibre spinning, or electrospinning is a process that produces polymer fibres by 
forcing an electrically charged jet of polymer solution. The jet evaporates and the polymer 
fibres are deposited on a collector (Huang et al., 2003; Laco et al., 2013). This scaffold 
fabrication method has been used for various biocompatible polymers, such as poly lactic-
co-glycolic acid (PLGA), PCL and polyurethane, successfully producing polymer fibres 
with diameters of <3 nm to >1 m (Fujihara et al., 2005). Although subject to low 
productivity and jet instability, the ability to control fibre thickness, scaffold diameter and 
pore size, as well as the ability to electrospin a highly porous (up to 90%) nanoscale scaffold, 
makes electrospinning a favourable scaffold fabrication technique in tissue engineering, and 
it has been used to produce PLLA membranes (Huang et al., 2003; Fujihara et al., 2005; 
Pham et al., 2006). 
 
Setup and Process 
The electrospinning setup is simple and consists of a syringe pump containing the polymer 
solution, a needle, a grounded collector and a high voltage source. To expose the polymer 
solution to an electrical field and induce an electrical charge to the surface of the solution, 
an electrode is positioned at the end of the needle near the liquid drop, while another 
grounded electrode is attached to the collector (Figure 4.1). Once the electric field 
overcomes the surface tension of the solution, a jet is ejected from the needle tip and the 
solution evaporates, and polymer fibres are ejected onto the collector. A stable 
electrospinning jet consists of four regions: the base, the jet, the splay and the collector 
(Huang et al., 2003; Pham et al., 2006). The jet is charged at the base region and emerges 
from the needle tip. A shape of the jet, known as the Taylor cone, is formed, and varies with 
the surface tension of the polymer solution and the strength of the electrical field. The jet 
evaporates and splays into several fibres before reaching the collector. A range of 
parameters, including viscosity, conductivity, surface tension, flow rate, applied voltage, gap 
distance between needle tip, and ambient variables, such as temperature and humidity, 
influence the process and the fibre diameter (Fujihara et al., 2005; Lanza et al., 2011). 
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Figure 4.1. Schematic illustration of electrospinning setup. Q = flow rate, V = applied 
voltage. 
 
Properties of Polymer Solution 
The viscosity varies according to the concentration of the polymer solution and affects the 
morphology of the electrospun fibres (Fong et al., 1999; Zong et al., 2002). Beading, a 
process where the fibres are assembled as droplets instead smooth fibres, is not desirable 
when electrospinning, and a correlation between low polymer concentrations and beading 
(Figure 4.2) has been reported. The polymer solution concentration also affects the fibre 
diameter, where higher concentrations increase the fibre diameter (Deitzel et al., 2001). 
Beading can be minimised or eliminated by increasing the charge density of the polymer 
solution by adding a saline solution to the polymer solution or by decreasing the surface 
tension. The latter can be achieved by adding alcohol to the solution (Zuo et al., 2005). 
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Figure 4.2. Relationship between beading and viscosity. Figure adapted from Huang et al.   
(Huang et al., 2003). 
 
Controllable Variables  
Several variables can be regulated to achieve the desired fibre morphology and diameter, 
and one such controllable variable is the polymer flow rate. Zong et al. (Zong et al., 2002) 
and Zuo et al. (Zuo et al., 2005) investigated the relationship between polymer flow rate and 
polymer fibre diameter, and concluded that low flow rates reduce the fibre diameter while 
high flow rates not only result in increased diameter, but also beading. Another controllable 
parameter that influences bead formation and fibre diameter is the intensity of the applied 
voltage. High voltage accelerates the solvent evaporation rates and in return results in 
smaller fibres due to fibre stretching, and increases the formation of smooth fibres (Zuo et 
al., 2005). Lastly, there should be an appropriate gap distance between the needle tip and the 
collector to ensure sufficient electric field strength and sufficient time for the polymer fibres 
to evaporate before reaching the collector (Pham et al., 2006). An increased distance leads 
to decreased fibre diameter but can also obstruct the electrospinning, while reducing the 
distance can result in wet fibres, as the polymeric solution has insufficient time to evaporate 
before being deposited onto the collector. This can form a scaffold of clustered fibres, as the 
fibres tend to stick to each other and to the collector (Ki et al., 2005; Pham et al., 2006).  
 
Ambient Variables 
Temperature and humidity both affect the electrospinning process (Mit‐Uppatham et al., 
2004). An increase in temperature can cause reduced polymer solution viscosity, which leads 
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to smaller fibres. An increase in humidity can result in small circular cracks on the fibre 
surface (Casper et al., 2004). 
 
4.1.1 Materials and Methods  
Electrospinning, as described in Section 3.2, Electrospinning, was used, and the 
electrospinning parameters listed in Table 3.1 and 3.2 were applied to electrospin PLLA 
membranes dissolved in chloroform and HFIP, respectively. PLLA fibre diameter, pore size 
and membrane thickness were visualised with SEM and calculated using ImageJ as 
described in Section 3.7, PLLA Membrane Characterisation. 
 
4.1.2 Results  
Electrospun PLLA Membranes 
All electrospun membranes were made of randomly aligned fibres. The SEM images show 
that all PLLA membranes produced with PLLA in chloroform had non-homogenous fibres 
and various beads; Figure 4.3 shows SEM image of sample A3Chlor (see Table 3.1 in Section 
3.2 for details on the applied electrospinning parameters). All samples with PLLA in 
chloroform were therefore excluded from the study. Few beads were detected in one specific 
area in sample O (see Table 3.2 in Section 3.2 for electrospinning parameters used) where 
the sample contained larger fibres. However, this was considered an error during the 
electrospinning process in which the voltage had decreased remarkably for a short period 
(Figure 4.3). 
 
 
Figure 4.3. SEM images of sample A3Chlor showing numerous beads on the fibres and of 
sample O showing a specific area on the PLLA membrane with few beads. Sample A3Chlor 
scale bar = 200 m, sample O scale bar = 20 m. 
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For fibre thickness analysis, samples A1, B1, B5 and O (see Table 3.2 in Section 3.2 for 
details on electrospinning parameters) were used (Figure 4.4).  
Samples A1 and O were compared to investigate the effect of altered gap distance, and no 
difference in fibre thickness was detected (Figure 4.5 A). The fibre thickness could be 
increased by decreasing the applied voltage from 20 kV to 15 kV, resulting in a significant 
difference in the fibre thickness of sample B5, which had the largest fibre diameters (Figure 
4.5 B). Nevertheless, the fibre thickness of sample B5 had a large SD, indicating great 
differences in the fibre diameters within the sample. Lastly, the fibre thickness in samples O 
and B1 was compared and showed that increased polymer solution concentration 
significantly increased fibre thickness (Figure 4.5 C).  
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Figure 4.4 A) SEM images of electrospun PLLA fibres of samples A1 (8% w/v PLLA, gap 
= 15 cm, 20 kV), B1 (10% w/v PLLA, gap = 12 cm, 20 kV), B5 (10% w/v PLLA, gap = 12 
cm, and 15 kV) and O (8% w/v PLLA, gap = 12 cm, 20 kV). Scale bar = 5 m and n = 30. 
B) PLLA fibre diameter distribution.  
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Figure 4.5. Comparison of fibre thickness following alteration of (A) gap distance, (B) 
voltage, and (C) PLLA solution concentration. **p < 0.01, ***p < 0.001 and n = 30. 
  
There was a correlation between fibre thickness and pore size, as samples with thin fibres, 
such as samples A1 and O, also had smaller pores, while samples with larger pores, such as 
samples B1 and B5, had thicker fibres (Figure 4.6). 
 
 
 
 
 
 
 
 
 
 
Distance
A
1 O
0
100
200
300
400
15 cm
12 cm
Samples
F
ib
re
 t
h
ic
k
n
e
s
s
 (
n
m
)
Voltage
B
1
B
5
0
200
400
600
800
20 kV
15 kV
***
Samples
F
ib
re
 t
h
ic
k
n
e
s
s
 (
n
m
)
Concentration
O B
1
0
100
200
300
400
500
8 %
10 %
**
Samples
F
ib
re
 t
h
ic
k
n
e
s
s
 (
n
m
)
A 
B
A 
C
A 
 50 
 
 
 
    
Figure 4.6. Comparison of fibre thickness (A) and pore size (B) in samples A1, B1, B5 and 
O. *p < 0.05, **p < 0.01, ***p < 0.001 and n = 30. 
 
The membrane thickness was measured using ImageJ and from the SEM images obtained; 
compact areas along the edge of the membrane wall of samples O and B1 were detected 
(Figure 4.7). These areas were caused by pressure applied on the surgical blade when cutting 
out the samples, rendering it difficult to achieve exact measurements of the membrane 
thickness of samples A1 and B5, as the fibres may have been exposed to forces affecting the 
membrane thickness. The membrane thickness should be investigated further to ensure 
correct measurements. A possibility for improving the measurement includes freezing the 
membranes with liquid N2 prior to the SEM, and breaking the samples to achieve a more 
even cut along the edges of the membranes. 
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Figure 4.7. (A) SEM images of the PLLA membrane wall showing membrane thickness of 
samples A1, B1, B5 and O. Scale bar = 20 m. (B) Scale bar = 20 m and n = 30. 
 
 Electrospun PLGA 
PLGA membranes were electrospun and SEM showed non-beaded PLGA fibres on the 
membranes (Figure 4.8). Degradation of the membranes was visible after 3 days and on the 
4th day there were several holes in the electrospun PLGA membranes (Figure 4.9A) whereas 
membranes sterilised with 80 % ethanol were still intact (Figure 4.9 B). UV light is known 
to enhance the degradation process and is not considered as the best sterilisation approach 
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for these thin electrospun PLGA membrane. Nevertheless, ethanol is known to have adverse 
effect on scaffolds such as structural and biochemical changes of the scaffold (Dai et al., 
2016). These electrospun PLGA membranes were eliminated as potential membranes for the 
in vitro bronchial mucosa model due to the fast degradation of the membranes.  
 
 
 
Figure 4.8. SEM images of electrospun PLGA fibres without beads. Scale bar = 5 m 
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Figure 4.9. Electrospun PLGA membrane mounted on CellCrown cell culture inserts. A) 
shows the 1h UV sterilised PLGA membranes submerged in DMEM cell culture medium 3 
and 4 days where degradation of the PLGA membranes was visible after 4 days. B) shows 
the PLGA membranes sterilised with 80% ethanol and submerged in culture medium for 3 
and 4 days. The PLGA membranes are intact and did not show any degradation after 3 and 
4 days. 
 
4.2 Protein Conformation on PLLA Surfaces: Col IV, FN and 
LM 
The conformation of Col IV, FN and LM on spin-coated PLLA surfaces was investigated. 
As mentioned in Chapter 1, Col IV and LM are the main components of the basement 
membrane framework. Vanterpool et al. (2014) have shown different protein conformations 
on PMA and PEA surfaces (Vanterpool et al., 2014). PEA surfaces promoted the 
spontaneous formation of FN fibre networks, whereas PMA surfaces preserved the globular 
A) UV 1h 
B) 80%  
Ethanol  
3 days 4 days 
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structure of FN. Various synergy sequences and integrin binding sites were exposed as a 
result of the FN fibre network formation, leading to larger FAs. 
  
4.2.1 Materials and Methods 
Col IV, FN and LM were used for protein adsorption assays as described in Section 3.3, 
Protein Adsorption.  
AFM was used to assess the protein conformations on PLLA surfaces (see Section 3.10, 
Atomic Force Microscopy). 
 
4.2.2 Results  
Protein Adsorption and Conformation of Col IV, FN, and LM 
Col IV (20 μg/mL and 50 μg/mL) were coated and incubated on spin-coated PLLA samples 
for 10 minutes for protein adsorption and conformation characterisation, respectively. 
Interconnected Col IV fibres were observed at both concentrations; however, 50 μg/mL Col 
IV generated a more interconnected fibre network (Figure 4.10 A and B). The 
hydrophobicity of the substrate surfaces affects the amount of protein adsorbed and the 
protein conformation on the surfaces (Altankov e Groth, 1994). The formation of the Col IV 
fibre network on the PLLA surface, which is highly hydrophobic, could be induced by the 
energetic interactions that occur between the molecular groups of Col IV and the PLLA 
surfaces, as previously described in section 1.3.4, rather than entropic interactions, which 
improve protein adsorption on hydrophobic surfaces. 
The conformation of LM was more globular on the PLLA surface; nevertheless, the height 
and globular conformation of LM on the surfaces showed protein adsorption on the PLLA 
samples (Figure 4.10 C). Hochman-Mendez et al. (2014) have shown that polymerised LM 
(PolyLM) diluted in acidic buffer, such as sodium acetate (pH 4), forms a structural network 
on glass, whereas LM in neutral buffer (pH 7) forms protein clusters on glass (Hochman-
Mendez et al., 2014). Globular FN conformation was observed on PLA surfaces (Figure 
4.10 D).  
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Figure 4.10. Protein adsorption assay. AFM of proteins on spin-coated PLLA surfaces. (A) 
Col IV (20 g/mL), (B) 50 g/mL Col IV, (C) 20 g/mL LM. (A and B) Col IV fibre 
networks on the PLLA surfaces where the network in (B) is more interconnected compared 
to (A). (C) LM did not form a fibre network but expressed a more globular structure. (D) 
AFM of FN conformation on PLLA surface observed in a separate study by Mark Sprott 
(PhD student), who is part of Prof Salmeron-Sanchez’s research group. (E) Surface control 
(PLLA spin-coated only).  Scale bar = 1 cm × 1 cm. 
 
4.3 Cell Adhesion on Fibronectin Coated Electrospun 
Membranes 
The interaction between cells and biomaterials is of great importance in various scientific 
areas, especially in tissue engineering (Gumbiner, 1996). Unlike the direct interaction 
between cells and synthetic polymers, intermediate adsorbed ECM protein layers, such as 
FN, enhance cell attachment, which plays a key factor in cell proliferation, viability, 
differentiation and phenotypic response (Sipe, 2002). Integrins are transmembrane receptors 
containing an - and a  subunit, which play a key role in cell attachment. Cell attachment 
occurs when several cell adhesion complexes consisting of integrins and cytoplasmic 
proteins such as actin, talin, vinculin and paxillin are formed as a result of ECM protein 
binding to the integrins. These cell adhesion complexes are responsible for FAs and signal 
transduction by the inside-out and outside-in signalling pathways. FN attaches to numerous 
integrins, and the most well-known FN receptor is 51 integrin, which binds to the RGD 
domain of FN (Griffith e Naughton, 2002; Sipe, 2002; Xu e Mosher, 2011; Vanterpool et 
D 
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al., 2014). A previous study has shown positive hTERT fibroblast response on cell–protein–
material configuration using FN and poly(ethyl) acrylate (PEA) (Vanterpool et al., 2014). 
For this project, PEA was used for comparison purposes, while PLLA was the polymer of 
interest due to its biodegradability and processability in manufacturing membranes. 
 
4.3.1 Materials and Methods 
The hydrophobicity of FN-coated electrospun PLLA membranes was assessed by measuring 
the water contact angle (see Section 3.11, Water Contact Angle). 
hTERT dermal fibroblasts for FA assay were cultured as described in Section 3.4, Cell 
Culture. 
FAs were assessed with immunostaining as described in Section 3.5, Focal Adhesions, and 
visualised under epifluorescence microscopy (Section 3.9 Focal Adhesion and Cell 
Morphology). 
 
4.3.2 Results  
Hydrophobicity Assay  
PLLA is a strongly hydrophobic polymer and has low affinity with cells (Xiao et al., 2011). 
To reduce the PLLA hydrophobicity, FN was coated onto the electrospun PLLA membrane 
and the hydrophobicity was assessed by measuring the static water contact angle. The PLLA 
membrane were coated with FN for 10 minutes, N2-dried, and the water contact angle of 
FN- and non–FN-coated PLLA surfaces was measured. The contact angle of the water drops 
on the non–FN-coated surfaces was significantly larger (p < 0.0001) than that of the FN-
coated surfaces (Figure 4.11 A). Likewise, this was observed on images of the water drops 
dispensed onto the FN- and non–FN-coated PLLA membrane surfaces (Figure 4.11 B and 
C). 
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Figure 4.11. Hydrophobicity analysis of FN- and non–FN-coated PLLA using static water 
contact angle measurements. (A) The difference in water contact angle of FN- and non–FN-
coated PLLA membranes. (B and C) Images show the form of the water drop on non–FN- 
(B) and FN-coated (C) PLLA surfaces. ***p < 0.0001. 
 
Cell Adhesion 
To investigate cell adhesion, PEA and PLLA surfaces were coated with FN to yield a 
controlled protein interface. Fibroblasts were seeded at low density (5000 cells/cm2) on the 
FN-coated surfaces for cell adhesion assay and cultured overnight (approximately 16 hours). 
Cells seeded on the FN-coated samples were widely spread and expressed well-developed 
FA plaques for both polymers as compared to samples without FN coating (Figure 4.13 and 
Figure 4.14).  
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Figure 4.12. Cell response on PEA surface. hTERT dermal fibroblasts on PEA surface A) 
without and B) with FN coating. The cells were stained for actin (green) and vinculin (red), 
and the nuclei were stained with DAPI (blue). Scale bar = 50 m. 
A 
B 
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Figure 4.13. Cell response on PLLA surface. hTERT fibroblasts on PLLA surface A) without 
and B) with FN coating. The cells were stained for actin (green) and vinculin (red), and the 
nuclei were stained with DAPI (blue). Scale bar = 50 m. 
 
FA maturation levels on different samples were quantified by the distribution size of the FA 
length of the major axis of the FA adhesion plaque, while FA complexes (FA complexes < 
1 μm) were excluded from the analysis. Figure 4.14 shows the size distribution histogram of 
the FA length and areas of cells cultured on FN-coated PEA and PLLA surfaces.  
 
    
 
 
 
 
Figure 4.14. Size distribution histogram of FAs on FN-coated PEA and PLLA surfaces. (A) 
The length of the major axis of the FA. (B) The area of the FA. 
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Figure 4.15. Assessment of FA of hTERT dermal fibroblasts cultured on PEA and PLLA 
surfaces coated with 20 μm/mL FN solution. (A) shows the median FA length, (B) median 
FA area and (C) shows cell size of hTERT fibroblasts on FN coated PEA and PLLA surfaces. 
Graphs A and B shows significantly longer and larger FAs of fibroblasts cultured on FN 
coated PLLA compared to fibroblasts cultured on FN coated PEA. *p < 0.05. 
 
The median of both the FA length and FA area were significantly larger for PLLA samples 
compared to PEA samples (p < 0.05) (Figure 4.15 A and B) while cells cultured on PLLA 
surfaces were slightly larger; however, this was not noteworthy (Figure 4.15 C).   
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4.4 Cell Behaviour: HBEpiCs, HUVECs and hTERT Dermal 
Fibroblasts on Col IV-, FN- and LM-coated PLLA Surfaces  
 
The cellular responses HBEpiCs, hTERT dermal fibroblasts and Human Umbilical Vein 
Endothelial Cells (HUVECs on protein-coated PLLA surfaces were investigated. HBEpiCs, 
hTERT dermal fibroblasts and HUVECs were seeded on PLLA surfaces coated with Col IV, 
FN, LM or a combination of Col IV and LM to study the cellular behaviour and morphology. 
Fibroblasts are abundant in the lamina propria, while both epithelial cells and endothelial 
cells are often found in the inner lining of tissues, acting as a barrier layer between the 
external environment and the underlying tissue layers (Martini et al., 2012). 
 
4.4.1 Materials and Methods 
The hydrophobicity of FN-coated electrospun PLLA membranes was assessed by measuring 
the water contact angle (see Section 3.11, Water Contact Angle). 
 
The cells were cultured as described in Section 3.4, Cell Culture. 
 
The morphology of the three cell types was assessed with immunostaining as described in 
Section 3.5, Focal Adhesions and Cell Morphology, and visualised with epifluorescence 
microscopy (Section 3.9, Focal Adhesion Assay and Cell Morphology). 
 
4.4.2 Results  
Cell Morphology  
All three cell types exhibited larger areas when cultured on FN-coated PLLA surfaces 
compared to other protein coatings (Figure 4.16, Figure 4.17, and Figure 4.18); however, no 
difference was observed for HUVECs cultured on FN- and Col IV-10+LM-10–coated 
surfaces. 
Unlike the LM-coated PLLA surface, all cell types appeared more spread out on FN-coated 
PLLA surfaces, as shown in C and D of Figure 4.16, Figure 4.17, and Figure 4.18.  
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Figure 4.16. Morphology assay. HBEpiCs on spin-coated PLLA surfaces coated with 20 
g/mL Col IV (Col IV-20), FN (FN-20), LM (LM-20) or 10 g/mL Col IV plus 10 g/mL 
LM (Col IV-10+LM-10). (A) Mean cell area. (B) HBEpiCs on FN- and (C) LM-coated 
PLLA surfaces. The cells were stained for actin (green) and the nuclei were stained with 
DAPI (blue). Scale bar = 50 m, n = 6. ****p < 0.0001. 
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Figure 4.17. Assessment of (A) cell area HUVECs on spin-coated PLLA surfaces coated 
with 20 g/mL Col IV (Col IV-20), FN (FN-20), LM (LM-20) or 10 g/mL Col IV plus 10 
g/mL LM (Col IV-10+LM-10). (A) Mean cell area. (B) HUVECs on FN- and (C) LM-
coated PLLA surfaces. The cells were stained for actin (green) and the nuclei were stained 
with DAPI (blue). Scale bar = 50 m, n = 6. ****p < 0.0001. 
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Figure 4.18. Assessment of (A) cell area of hTERT dermal fibroblasts on spin-coated PLLA 
surfaces coated with 20 g/mL Col IV (Col IV-20), FN (FN-20), LM (LM-20) or 10 g/mL 
Col IV plus 10 g/mL LM (Col IV-10+LM-10). (A) Mean cell area. (B) hTERT fibroblasts 
on FN- and (C) LM-coated PLLA surfaces. The cells were stained for actin (green) and the 
nuclei were stained with DAPI (blue). Scale bar = 50 m, n = 6. ***p < 0.0001. 
 
Focal Adhesions 
The HBEpiC FAs were similar in both size and area for all protein types coated on the PLLA 
surfaces (Figure 4.19). The same was observed for HUVEC FAs; nevertheless, the HUVEC 
FAs were larger in both size and area compared to that of the HBEpiCs (Figure 4.19 and 
Figure 4.20). The fibroblast FAs were larger for cells cultured on Col IV–coated PLLA 
surfaces compared to cells cultured on FN-coated surfaces (p < 0.05) (Figure 4.21 A). There 
was a significant difference between the FA areas of fibroblasts cultured on Col IV–coated 
PLLA surfaces and on FN- and Col IV+LM–coated surfaces (p < 0.05 and p < 0.01, 
respectively) (Figure 4.21 B). Furthermore, fibroblasts cultured on LM-coated surfaces had 
significantly larger FA areas compared to that on FN-coated surfaces (p < 0.05). 
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Figure 4.19. FA assay. HBEpiCs on spin-coated PLLA surfaces coated with 20 g/mL Col 
IV (Col IV-20), FN (FN-20), LM (LM-20) or 10 g/mL Col IV plus 10 g/mL LM (Col IV-
10+LM-10). (A) Mean FA size. (B) Mean FA area. (C) Immunostaining for FA. The cells 
were stained for actin (green) and vinculin (red), and the nuclei were stained with DAPI 
(blue).. Scale bar = 50 m. 
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Figure 4.20. FA assay for HUVECs on spin-coated PLLA surfaces coated with 20 g/mL 
Col IV (Col IV-20), FN (FN-20), LM (LM-20) or 10 g/mL Col IV plus 10 g/mL LM (Col 
IV-10+LM-10). (A) Mean FA size. (B) Mean FA area. (C) Immunostaining for FA. The 
cells were stained for actin (green) and vinculin (red), and the nuclei were stained with DAPI 
(blue).  Scale bar = 50 m. 
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Figure 4.21. FA assay for hTERT dermal fibroblasts on spin-coated PLLA surfaces coated 
with 20 g/mL Col IV (Col IV-20), FN (FN-20), LM (LM-20) or 10 g/mL Col IV plus 10 
g/mL LM (Col IV-10+LM-10). (A) Mean FA size. (B) Mean FA area. (C) Immunostaining 
for FA. The cells were stained for actin (green) and vinculin (red), and the nuclei were 
stained with DAPI (blue).  Scale bar = 50 m. *p < 0.05, **p < 0.001. 
 
 
FN
C
ol
 IV
 2
0
LM
 2
0
C
ol
 IV
 1
0 
+ 
LM
 1
0
0
1
2
3
4
F
A
 s
iz
e
 (
m
m
)
*
FN
C
ol
 IV
 2
0
LM
 2
0
C
ol
 IV
 1
0 
+ 
LM
 1
0
0
1
2
3
4
F
A
 a
re
a
 (
µ
m
2
)
**
*
*
C
A 
A B 
 72 
4.5 Establishing Optimised Culture Conditions for Epithelial 
Cells and Fibroblasts  
Several optimisation experiments were performed to achieve an optimised long-term culture 
model that could support and maintain an in vitro mucosa model. HBEpiCs and hTERT 
dermal fibroblasts were used for all experiments to regenerate bronchial mucosa in vitro. 
In the mucosa, the basement membrane is the basal ECM on which the epithelium rests and 
it forms a 3D network in vivo, consisting mainly of Col IV and LM (Weiss, 1988; Gartner e 
Hiatt, 2007; Gartner et al., 2011). This network regulates cell adhesion, differentiation, 
proliferation and migration (Lanza, 2011). Different from 2D culture systems, 3D cell 
culture systems produce a more precise representation of the in vivo microenvironment and 
cellular behaviour (Edmondson et al., 2014) due to the morphological and physiological 
behaviour of the cells yielding a more accurate in vivo–like cell response, as they are 
surrounded by other cells and ECM. This was the rationale for choosing an ALI 
configuration, which resembles the physiological structure of the basement membrane and 
provides structural properties, including a porous 3D microenvironment, that allow the 
diffusion of nutrients and waste products, and gas exchange. Another important aspect of 
choosing an ALI cell culture model is to maintain the barrier function and polarity of the 
epithelial layer during mucosa regeneration in vitro (Morris et al., 2014). The FN-coated 
electrospun PLLA membranes were intended to function as a substitute for the basement 
membrane and were coated on both the apical and basal side of the membranes to optimise 
cell attachment.  
 
4.5.1 Materials and Methods 
Excessive polymer solvents were removed as described in Section 3.2, Electrospinning 
PLLA Membranes. 
Primary HBEpiCs and hTERT dermal fibroblasts were cultured as described in Section 3.4, 
Cell Culture. 
Cells were immunostained for E-cadherin and nuclei (DAPI) and visualised as described in 
Section 3.4, Air–Liquid Interface Culture. 
 
Polymer Dissolvent Removal  
To study the cellular behaviour of HBEpiCs after the removal of polymer dissolvent, in this 
case HFIP, the PLLA samples were vacuum-dried for 4 hours at 60C and compared with 
non–vacuum-dried PLLA membranes and glass surfaces. All three surface types were coated 
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with 20 g/mL FN, and HBEpiCs were seeded and cultured for 1 week at seeding densities 
of 25 × 103 cells/cm2, 50 × 103 cells/cm2 and 75 × 103 cells/cm2 to achieve an optimised cell 
seeding density with a fully confluent monolayer to enhance cell–cell contact. The cells were 
stained for E-cadherin as described in Section 3.5, ALI Culture. 
 
4.5.2 Results 
Cell seeding  
The electrospun PLLA membranes were vacuum-dried for 4 hours to ensure a non-toxic 
environment for the cells and to enhance cell attachment. The non–vacuum-dried PLLA 
samples (ES PLLA, as spun) showed less HBEpiCs when compared to HBEpiCs on the 
control glass samples and vacuum-dried PLLA samples (Figure 4.22). The cell seeding 
densities of 50 × 103 cells/cm2 and 75 × 103 cells/cm2 showed an almost fully confluent layer 
of HBEpiCs on the vacuum-dried membranes compared to the seeding density of 25 × 103 
cells/cm2. Nevertheless, cells cultured on the glass surfaces appeared larger compared to 
cells cultured on the PLLA membranes, and the intercellular adherens junctions function (E-
cadherin) was more prominent. 
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Figure 4.22. HBEpiC seeding densities of 25 × 103 cells/cm2, 50 × 103 cells/cm2 and 75 × 
103 cells/cm2 on glass, ES PLLA (as spun) and vacuum-dried electrospun PLLA membranes. 
All surfaces were coated with 20g/mL FN.  More HBEpiCs were observed on the vacuum-
dried PLLA membranes compared to the ES PLLA membranes. The cells were stained for 
E-cadherin (red) and the nuclei were stained with DAPI (blue). Scale bar = 50 m. 
 
Cellular Behaviour on FN-Coated PLLA Surface 
To study the cellular responses of HBEpiCs and fibroblasts on FN-coated PLLA membranes, 
both cell types were cultured separately over 7 days on PLLA membranes with or without 
FN coating. SEM images showed substantially improved attachment and growth of cells 
cultured on FN-coated membranes (Figure 4.23). Furthermore, the SEM images revealed 
how the FN-adsorbed PLLA fibres facilitated cell spreading and adherence on the fibres. 
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Figure 4.23. SEM of (A) HBEpiCs and (B) hTERT dermal fibroblasts cultured individually 
on PLLA membranes with or without FN coating. The cells were cultured over 7 days. Scale 
bar = 20 µm. 
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4.6 Discussion and Conclusions 
Regarding the studies in this chapter, the aims were to develop a suitable porous biomaterial 
that could support cell attachment and growth. PLLA was electrospun, creating nanofibre 
membranes to establish a fibrous and porous network mimicking the basement membrane 
structure. Various properties of the electrospun membranes, such as fibre thickness, porosity 
and surface area to volume ratio, could be manipulated to achieve a close resemblance of the 
natural ECM (Doshi e Reneker, 1995; Fujihara et al., 2005). In this study, a high surface 
area for cell adhesion was desired, and was accomplished by producing nanofibre 
membranes with approximately 240-nm fibre diameter. The process of creating smooth 
fibres and avoiding the formation of droplets and beads, and optimization of the 
electrospinning parameters was required. Most of these parameters, including applied 
voltage, polymer concentration, gap distance, flow rate, temperature and humidity, were kept 
constant for both solvents, i.e. chloroform and HFIP. However, with HFIP, it was possible 
to achieve PLLA fibres, unlike chloroform. Numerous studies on electrospinning have 
indicated the importance of solvent selection, as its main roles are to dissolve the polymer 
and to transport the dissolved polymer to the collector (Gu et al., 2014). Solvent properties 
such as surface tension, dielectric constant, density and boiling point influence the 
morphology of the electrospun fibre (Bhardwaj e Kundu, 2010). Doshi et al. (1995) have 
indicated that a decrease in the surface tension of a polymer solution affects the formation 
of bead-free fibres (Doshi e Reneker, 1995); however, low solvent surface tension does not 
always result in smooth fibres. A high dielectric constant improves solution conductivity 
and thus facilitates the fabrication of smooth fibres. HFIP has a higher dielectric constant 
compared to chloroform, i.e. 16.7 vs. 4.8, whereas the surface tension of chloroform is 26.5 
mN/m and that of HFIP is 16.7 mN/m (Gu et al., 2014). From the present findings, it is 
believed that the higher dielectric constant of HFIP could have affected the achieved non-
beaded smooth PLLA fibres. One main focus of this project was to apply the ECM proteins 
found mainly in the basement membrane, i.e. Col IV and LM, and in the underlying 
connective tissue layer, i.e. FN. While Col IV and LM form the basement membrane 
framework and improve the attachment and proliferation of some cells (Coelho et al., 2011; 
He et al., 2013), the present study showed that FN had a better effect on cell attachment. FN 
plays a key role in wound repair of epithelial cells and in regulating epithelial cell adhesion, 
proliferation and survival (Xiang et al., 2008) once it binds integrins. Protein conformation 
on synthetic polymer surfaces has been extensively studied, and Vanterpool et al. (2014) 
have demonstrated FN protein unfolding when it is adsorbed on PEA surfaces, exposing 
hidden binding sites for cells (Vanterpool et al., 2014). This was not observed in the present 
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optimisation studies, as FN retained its globular structure, while Col IV was the only ECM 
protein that created a fibre network. ECM protein adsorption on synthetic polymer surfaces 
facilitates cell–material interactions by improving cell adhesion and the biocompatibility of 
polymers (Salmeron-Sanchez e Altankov, 2010). The present study shows how FN-adsorbed 
PLLA surfaces improved the attachment of three cell types: fibroblasts, HBEpiCs and 
HUVECs.  
 
This study has demonstrated the ability to electrospin an appropriate non-beaded 
nanofibrous PLLA membrane with homogenous fibres. Based on analysis of the membranes, 
HFIP is a reliable solvent for electrospun PLLA membranes as compared to chloroform. 
Samples A1 and B1 met the objectives of the project, as they consisted of more homogenous 
nanofibres, thus increasing the surface area to volume ratio and with no beading. 
Furthermore, the range of membrane fibre thickness was correlated with alterations in the 
parameters, such as the voltage and the PLLA solution concentration. For all further 
experiments using PLLA membranes, electrospun samples produced under the same 
conditions as sample A1 were applied. For future work, it is suggested that the method for 
measuring the membrane thickness, as described previously, be improved. 
The present study also shows that using FN as an intermediate protein adsorption layer 
improves hTERT dermal fibroblast adhesion and differentiation regardless of whether the 
underlying polymeric layer is PEA or PLLA. By applying an intermediate FN adsorbed layer 
to two chemically different polymer surfaces, it was possible to show the influence FN has 
on the development of FA, FA length and area, and cell proliferation and spreading. This 
experiment demonstrated that, when coated with an intermediate FN layer, both polymers 
are suitable for hTERT dermal fibroblast culture; however, PLLA will be used for further 
work in this project due to its biodegradability. AFM characterization was used to investigate 
the conformation of Col IV, LM and FN on PLLA surfaces. The results showed the 
formation of interconnected Col IV fibres on PLLA at both low and high concentrations, 
where the fibre networks were more enhanced at the higher concentrations. Both FN and 
LM adsorbed on the PLLA surfaces and formed a globular conformation, but network 
conformation was not observed. 
There was greater cell spreading of all three cell types, i.e. HBEpiCs, HUVECs and hTERT 
dermal fibroblasts, on FN-coated samples, and the fibroblasts exhibited enhanced adhesion 
on the Col IV– and FN-coated samples. As FN has been widely used as an intermediate 
protein layer for cell cultures and because the findings of the present work and previous 
studies show enhanced cell attachment, FN was chosen for further in vitro cell cultures. 
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5. In Vitro Bronchial Mucosa 
Model   
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5.1 Introduction  
 
The human bronchial epithelium acts as a protective barrier and prevents microorganisms 
from entering the airways, which can have a great impact on biological mechanisms that 
cause airway diseases such as asthma and COPD. Such diseases can lead to airway 
remodelling, which affects the intercellular junctions between epithelial cells and causes 
poor permeability function (Martini et al., 2012; Morris et al., 2014; Steinke et al., 2014). 
Human in vitro airway models consisting of biomaterials, mimicking the basement 
membrane, offer mechanical support for tissue regeneration and ECM component 
deposition, while ALI cultures promote epithelial cell differentiation. 
 
In this chapter, a long-term in vitro bronchial mucosa model consisting of a well-
differentiated epithelial layer and an underlying fibroblast layer is developed. ALI models 
have been widely used to regenerate well-differentiated epithelium consisting of ciliated and 
secretory epithelial cells, such as airway and intestinal epithelium, or for skin models. Most 
of the established ALI culture models comprise cell culture inserts with a porous membrane 
such as PET and are coated with collagen (Figure 5.1). The membrane allows nutrient 
feeding from the basal compartment to the epithelial cells raised in ALI. Although studies 
have indicated the importance of fibroblasts in regulating epithelial cell proliferation, 
differentiation and mucin secretion, conventional in vitro airway models still often consist 
of 2D ALI-cultured epithelial monolayers (Kobayashi et al., 2006; Myerburg et al., 2007). 
Epithelial cells facilitate fibroblast migration and proliferation (Kobayashi et al., 2006; 
Myerburg et al., 2007) , along with the effect they have on bronchial epithelial cell 
proliferation and differentiation.  
 
In the first part of this chapter, the importance of incorporating an underlying fibroblast layer 
in an in vitro bronchial mucosa model and its role in establishing a well-differentiated 
epithelium is investigated. To do so, a robust ALI culture model consisting of FN-
functionalised electrospun PLLA membranes mimicking the basement membrane is 
presented. The PLLA engineered membranes were assessed and compared with 
conventional cell culture inserts containing PET membranes. Col IV and LM secretion was 
examined to evaluate the formation of a robust basement membrane consisting of the two 
proteins, which could potentially replace the PLLA membranes as they degrade. By applying 
the ALI model, it was possible to establish a long-term in vitro bronchial mucosa model that 
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could support primary HBEpiC morphology and polarity while promoting the proliferation 
of the underlying fibroblasts.  
 
 
Figure 5.1. Schematic illustration of conventional in vitro Air-Liquid Interface (ALI) culture 
models. The model consists of a semipermeable non-degradable membrane coated with or 
without collagen. Epithelial cells are seeded on the apical side of the membranes and raised 
in air to create an ALI culture setup. The cells receive nutrients through the basal side of the 
membrane. 
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5.2 Materials and Methods 
HBEpiCs and dermal fibroblasts were cultured as described in Section 3.4, Air-Liquid 
Interface Culture. 
 
Cell morphology was assessed with SEM (Section 3.7, Cell Morphology Assay). 
 
Col IV and LM secretion was assessed by immunostaining as described in Section 3.5, 
Protein Secretion, and visualised with epifluorescence microscopy. 
 
HBEpiCs were immunostained for E-cadherin and MUC5AC as described in Section 3.5, 
ALI Culture, and visualised with epifluorescence microscopy. To evaluate fibroblast 
morphology and presence, the cells were immunostained for S100A4, see Section 3.5, ALI 
Cultures. All nuclei were stained with DAPI. 
 
Histology assays of the in vitro bronchial mucosa tissue and ALI co-cultures of HBEpiCs 
and fibroblasts on Transwell cell culture inserts were performed as described in Section 3.8, 
Histology. 
 
HBEpiC cilia motility was recorded with high-speed video as described in Section 3.9, High-
speed Recording of Motile Cilia. 
 
The degradation rate of the electrospun PLLA membranes was measured as described in 
Section 3.12, Degradation Assay of PLLA Membranes. 
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5.3 Results  
5.3.1 HBEpiC Ciliation  
HBEpiCs were cultured separately or co-cultured with hTERT dermal fibroblasts in 
submerged culture for 1 week until a confluent layer of HBEpiCs was formed. To study the 
impact of the ALI culture setup on HBEpiC ciliation, the cells were raised in ALI and 
cultured for an additional 2 weeks (Figure 5.2), and their morphology was analysed with 
SEM.  
 
 
 
 
Figure 5.2. Schematic illustration of in vitro ALI co-culture model. The model includes an 
electrospun PLLA membrane functionalised with FN on both the apical and basal sides; 
HBEpiCs and hTERT dermal fibroblasts were seeded on the apical and basal sides, 
respectively, of the membrane. 
 
The SEM images showed a confluent HBEpiC layer in which epithelial cell adherens 
junctions could be observed. For HBEpiCs co-cultured with fibroblasts, SEM images 
showed areas of ciliated HBEpiC layers in both the ALI and non-ALI culture setups (Figure 
5.3). Moreover, the SEM images clearly show that cilia were more abundant in the ALI co-
culture configuration, while no HBEpiC ciliation was observed when the cells were 
individually cultured in ALI or non-ALI culture setups (Figure 5.3). This indicates the 
importance of the presence of fibroblasts and the role of an underlying fibroblast layer in 
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HBEpiC proliferation and differentiation. Some studies have suggested that retinoic acid 
improves epithelial cell differentiation when added to culture medium and when used in ALI 
culture setups (Dimova et al., 2005; O'boyle et al., 2018). Thus, in a separate study, retinoic 
acid was added to the culture medium for ALI co-cultures of HBEpiCs and fibroblasts over 
2 weeks to evaluate its effect on HBEpiC ciliation. The SEM images show that retinoic acid 
led to fewer viable HBEpiCs as well as fibroblasts and it was therefore not used for further 
ALI cultures (Figure 5.4).  
 
 
Figure 5.3. SEM of HBEpiC (red) individually cultured (Monoculture) or co-cultured with 
hTERT dermal fibroblasts (Co-culture) on FN coated electrospun PLLA membranes. The 
HBEpiCs were raised in ALI (+ALI) or cultured in a non-ALI (-ALI) setup. Cell culture 
period was over 14 days. Scale bar = 10µm. 
 
 84 
 
 
Figure 5.4. Human Bronchial Epithelial cells (HBEpiCs) and hTERT dermal fibroblasts 
were co-cultured in ALI for two weeks and retinoic acid was added to the cell culture 
medium. Cell proliferation and ciliation of HBEpiCs were analysed with SEM. Both cell 
types grew better in cell culture medium without retinoic acid (-RA) while addition of 
retinoic acid (+RA) caused lack of cell growth. Scale bar for HBEpiCs SEM images is 5m 
and scale bar for fibroblasts is 20m. 
 
5.3.2 Col IV and LM Secretion of HBEpiC and Fibroblasts 
HBEpiCs and fibroblasts cultured separately or co-cultured on either side of FN-coated 
PLLA membranes were stained for Col IV and LM to investigate protein secretion and were 
analysed with confocal microscopy. The confocal images showed that both cell types 
secreted ColIVα2 and LM after 2 and 7 days (Figure 5.5). The fibroblast-secreted ColIVα2 
formed a fibre network, unlike the HBEpiC-secreted ColIVα2. Both cell types also secreted 
LM, which was detected inside and around both cell types. 
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Figure 5.5. Confocal imaging of HBEpiC and hTERT dermal fibroblasts (Z-stack images, 
see arrow). (A) Z-stack images of HBEpiCs cultured on FN coated electrospun PLLA 
A B C D 
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ta
ck
 
 86 
membrane. (B) Z-stack images of fibroblasts cultured on FN coated PLLA electrospun 
membrane. (C) Z-stack images of HBEpiCs seeded on the apical side of FN coated PLLA 
membrane and co-cultured with fibroblasts seeded on the basal side of the membrane.  (D) 
Z-stack images of fibroblasts seeded on the basal side of FN coated PLLA membrane and 
co-cultured with HBEpiCs seeded on the apical side of the membrane. All culture samples 
were submerged in culture medium and cultured for 7 days. The cells were immunostained 
for ColIVα2 (green) and LM (magenta). Scale bar = 20 µm. 
 
5.3.3 Long-term ALI Co-culture  
To establish a long-term in vitro mucosa, the ALI HBEpiC and fibroblast co-culture was 
extended from 2 weeks to 4 and 6 weeks. The HBEpiC and fibroblast organisation and 
morphology were analysed with SEM and immunostaining, as described in Chapter 3. The 
presence of fibroblasts was confirmed with S100A4 staining (Figure 5.6) and the cell 
morphology was investigated using SEM. The fibroblasts expressed an elongated cell 
morphology which is characteristic for fibroblasts. It was clear that the functionalised PLLA 
fibres facilitated fibroblast proliferation and elongation, as the cells stretched along the 
fibres. E-cadherin immunostaining confirmed intercellular adherens junctions, and 
epifluorescence microscopy images showed a well-defined honeycomb organization of the 
HBEpiCs at week 2 and 4 (Figure 5.7). However, the honeycomb structure was not as 
defined after 6 weeks (Figure 5.7), which indicates the epithelial layer poor intercellular 
junctions between the HBEpiCs and epithelial cell polarity. The HBEpiCs were stained for 
MUC5AC to investigate whether they differentiated into mucin-secreting cells, also known 
as goblet cells, and mucin was detectable after 4 weeks of ALI culture (Figure 5.7). The 
positive apical MUC5AC and E-cadherin expression both suggested HBEpiC polarisation. 
The presence of ciliated HBEpiCs was more prominent after 4 weeks of ALI culture 
compared to 2 and 6 weeks of ALI culture. The cilia were approximately 2–5 m long after 
2 weeks’ ALI culture and increased to approximately 10 m length after 4 weeks’ ALI 
culture, resembling the in vivo morphology of epithelial cilia more closely (Figure 5.8) 
(Gartner e Hiatt, 2007). Histology assays likewise showed that HBEpiC ciliation was present 
after week 2 and 4 of ALI culture (Figure 5.9). The histology images revealed increased 
epithelial layer thickness after 6 weeks’ ALI culture, which indicates that rapid cell 
proliferation occurred after week 4 of culture (Figure 5.9). Overall, the 2- and 6-week ALI 
co-cultures showed poor ciliation, and no goblet cells were observed. Cilia motility was 
analysed by observing beating cilia and was recorded by high-speed video camera; beating 
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cilia were observed at week 4 of ALI culture. In Figure 5.10 shows how the cilia beat 
unidirectionally.  
 
 
 
 
Figure 5.6. hTERT dermal fibroblasts co-cultured with HBEpiCs in ALI for 2, 4 and 6 
weeks. The cells were stained for fibroblast-specific protein, i.e. S100A4 (red), and the 
nuclei were stained with DAPI (blue). Immunostaining scale bar = 50 µm, SEM scale bar = 
20 µm. 
Two weeks ALI 
Four weeks ALI 
Six weeks ALI 
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Figure 5.7. HBEpiCs co-cultured with hTERT dermal fibroblasts in ALI for 2, 4 and 6 
weeks. The cells were stained for E-cadherin (green) and MUC5AC (red), and the nuclei 
were stained with DAPI (blue). Immunostaining scale bar = 50 µm, SEM scale bar = 20 µm. 
 
 
Two weeks ALI 
Four weeks ALI 
Six weeks ALI 
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Figure 5.8. (A) SEM images of HBEpiC cilia after 2 and 4 weeks of ALI co-culture with 
hTERT dermal fibroblasts. Scale bar = 5 µm. (B) Length of HBEpiC ciliae after 2 and 4 
weeks of ALI co-culture with dermal fibroblasts. ****p < 0.0001 and n=15. 
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Figure 5.9. HBEpiC ciliation could be observed at week 2 and 4 of ALI culture, while no 
cilia were observed at week 6 of ALI culture. Scale bar = 50 µm. 
 
Two weeks ALI 
Four weeks ALI 
Six weeks ALI 
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Figure 5.10. Snapshots of high-speed video recordings of motile HBEpiC cilia after 4 weeks’ 
ALI co-culture with hTERT dermal fibroblasts. White circles indicate the area where beating 
cilia were detected; white arrows indicate the direction in which the cilia were beating. 
Snapshots were taken every 20th part of a second. Scale bar = 50 µm (horizontal length of 
each image). 
 
5.3.4 Transwells PET Membranes vs. PLLA Electrospun Membranes 
The cellular behaviour of HBEpiCs and fibroblasts on FN-coated PLLA membranes was 
compared with that on porous synthetic membranes forming a part of commercially available 
Transwell cell culture inserts. These culture inserts often consist of PET membranes with 
various pore sizes. Both HBEpiC and fibroblast proliferation was assessed; most 
importantly, the HBEpiC differentiation characteristics were of interest. PET and PLLA 
membranes were coated with FN, and HBEpiCs and fibroblasts were co-cultured in ALI for 
4 weeks as previously described. The co-culture samples were assessed with histology 
staining, and images of cross-sectioned samples were analysed (Figure 5.11). The PET 
membranes were thicker than the PLLA membranes, thus creating a greater distance 
between the HBEpiC and fibroblast layers. Furthermore, the histology assays showed 
decreased HBEpiC layer thickness for cells cultured on the FN-coated PET membranes. The 
HBEpiCs spread and grew well on the PLLA membranes, and HBEpiC cilia were only 
detectable on ALI cultures containing the PLLA membranes. 
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Figure 5.11. Histology assays of HBEpiCs and hTERT dermal fibroblasts co-cultured in ALI 
on FN-coated Transwell cell culture inserts containing PET membranes, and on electrospun 
PLLA membranes. An apparent difference in membrane thickness was observed. Ciliated 
HBEpiCs were seen only on co-cultures on PLLA membranes, while decreased HBEpiC 
growth was observed on the PET membranes. Scale bar = 50 µm. 
 
5.3.5 Degradation of PLLA 
As part of the objectives of this research, PLLA was chosen due to its biodegradability. 
However, it was important to investigate the degradation characteristics of the electrospun 
PLLA to evaluate if it could provide structural support during the development of an in vitro 
bronchial mucosa. Being an aliphatic polymer, PLLA degradation occurs through a 
hydrolytic reaction and the degradation rate depends on, among other parameters, the 
dimensions of the polymer. For the degradation assay of the electrospun PLLA, membranes 
were cut into 2 × 2 cm squares and submerged in DMEM culture medium for 2, 4 and 6 
weeks. At 2, 4, and 6 weeks the membranes were N2-dried and the degradation process was 
assessed by investigating the mass loss of the membranes. No changes in membrane mass 
loss were detected after 2-week culture, while 13.33% and 17.80% mass loss was observed 
at week 4 and 6, respectively (Figure 5.12). Furthermore, the PLLA membrane thickness 
used in the long-term in vitro model was investigated. Histology assay at week 4 and 6 
revealed an apparent decrease in membrane thickness (Figure 5.9). 
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Figure 5.12. Mass loss of electrospun PLLA membranes after 2, 4 and 6 weeks in DMEM.    
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5.4 Discussion and Conclusions   
The mucosa is the first point of contact with external microorganisms and is a vital tissue 
layer in most organs because it prevents injury to the underlying tissues. An ideal in vitro 
mucosa model consists of a well-differentiated and polarised epithelium, cell-synthesised 
basement membrane and lamina propria, all mimicking the in vivo mucosa in terms of both 
morphology and functionality (Steinke et al., 2014). Another important factor of such an 
ideal model is the use of human-derived cells rather than animal cells to achieve a more 
exact representation of the in vitro model. Most of the established in vitro airway models 
include an epithelial layer cultured on synthetic porous membranes, often functionalised 
with collagen (Lin et al., 2007; Skibinski et al., 2007; Parker et al., 2010). The epithelial 
cells are then raised in an ALI to mimic epithelium exposure to air in vivo and to promote 
cell differentiation. Such epithelial models overlook the paracrine interactions that occur 
between the epithelium and the underlying tissues, such as the lamina propria, which mainly 
contains fibroblasts. Fibroblasts play a key role in epithelial cell proliferation and 
differentiation, whereas epithelial cells are important for fibroblast migration and 
proliferation (Kobayashi et al., 2006; Morris et al., 2014). A promising approach is to 
develop an in vitro mucosa model comprised of an epithelial and fibroblast layer to promote 
paracrine interactions. 
 
Cilia are motile extensions of the plasma membrane and facilitate the movement of mucus 
in the airways. They beat unidirectionally in a synchronised rhythm to constrain the 
backflow of secreted mucus (Gartner e Hiatt, 2007; Martini et al., 2012). In the first part of 
this study, the influence of ALI and fibroblasts on HBEpiC ciliation was investigated. The 
importance of an underlying fibroblast layer was evident from the above results, as ciliation 
was only observed in HBEpiC and fibroblast co-cultures regardless of the use of ALI. The 
ALI culture setup is, however, important for ensuring that the bronchial epithelial cells are 
cultured in an environment that mimics the airway as closely as possible. Moreover, the 
results showed more ciliated HBEpiCs in ALI co-cultures than in non-ALI co-cultures. 
Retinoic acid is a compound derived from vitamin A that influences the differentiation of 
various epithelial cell types; O’Boyle et al. (2018) demonstrated how retinoic acid enhances 
ovine airway epithelial cell ciliation (O'boyle et al., 2018). Retinoic acid was therefore 
incorporated in the cell culture medium for the ALI co-cultures to investigate its effect on 
HBEpiC ciliation. Unlike O’Boyle et al. (2018), the present study found that retinoic acid 
had a negative effect on not only HBEpiC ciliation, but also the growth of both HBEpiCs 
and fibroblasts, and it was thus eliminated as an option for promoting cell differentiation in 
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the ALI co-culture model. Cozens et al. (2018) have shown how the concentration of retinoic 
acid affects the ciliation of bovine bronchial epithelial cells using concentrations 0, 25, 50, 
100 and 250 nM of retinoic acid (Cozens et al., 2018). They demonstrated an increase in 
ciliated bovine bronchial epithelial cells with a peak at 100nM where after the ciliation of 
the epithelial cells decreased at higher concentration. Due to this link between retinoic acid 
concentration and ciliation of bronchial epithelial cells, future studies on the presented ALI 
co-culture model could include investigating the effect of different retinoic acid 
concentrations on HBEpiCs.  
  
Next, the ability of HBEpiCs to secrete their own basement membrane was evaluated, as 
epithelial cells naturally do so in vivo by synthesizing Col IV and LM. This was shown with 
the positive ColIVα2 and LM expression by the HBEpiCs and likewise for the hTERT 
dermal fibroblasts, which also synthesized and secreted both Col IV and LM. 
 
Epithelial cells are attached to each other through intercellular adherens junctions, which 
contribute to epithelial cell integrity and polarisation (Weiss, 1988; Gartner e Hiatt, 2007; 
Gartner et al., 2011). High HBEpiC seeding density was required to achieve this, and seeding 
densities of >1.5 × 105 cells/cm2 are generally recommended for primary airway epithelial 
cells to form a confluent monolayer in ALI cultures (You e Brody, 2012). A monolayer 
could be achieved by using a seeding density of 2.5 × 105 cells/cm2. E-cadherin expression 
was shown between the HBEpiCs and was visualised as a honeycomb structure, and 
confirmed the HBEpiCs polarisation.   
 
Ideal in vitro ALI culture models should support long-term cell culture to allow cell growth 
and differentiation. The ALI co-culture model was extended from 2 weeks to 4 and 6 weeks 
to investigate the features of HBEpiC differentiation into ciliated and mucin-secreting cells. 
While ciliation was observed after 2 weeks’ ALI co-culture, it was clear that these cilia were 
not the same length (10–15 m) as natural cilia found in vivo. Likewise, ciliated cells were 
scarce. The presence of mucin-secreting cells was assessed by staining for MUC5AC 
expression, which could not be detected after 2 weeks’ ALI co-culture. Extending the ALI 
co-culture for an additional 2 weeks made it possible to obtain well-differentiated HBEpiCs, 
as the number of ciliated epithelial cells increased and the cilia length increased to 10–15 
m. Unlike HBEpiCs cultured for 4 weeks in ALI, HBEpiCs cultured for 6 weeks in ALI 
showed poor ciliation. MUC5AC expression was also detected after 4 weeks’ ALI co-
culture. This confirms the importance of establishing a long-term culture model that enables 
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a confluent and well-differentiated epithelium. HBEpiCs cultured for 6 weeks in ALI 
showed poor proliferation and differentiation compared to HBEpiCs cultured for 4 weeks in 
ALI. Hence, these results suggest an optimal culture time of 4 weeks to establish an in vitro 
bronchial mucosa model, as this duration enables a well-differentiated and polarised 
epithelial layer. It is recommended that this model be used for in vitro airway studies around 
week 4 of ALI to yield in vitro bronchial mucosa that mimics in vivo mucosa tissue. Cilia 
motility was investigated with high-speed video recordings at week 4 of ALI co-culture 
because well-developed cilia and mucus secretion was only observed at that time point on 
both SEM and immunofluorescence microscopy. 
 
A key aspect of the presented ALI co-culture configuration is the type of material on which 
the cells were cultured. Most existing models use non-degradable porous materials such as 
commercially available Transwell cell culture inserts containing PET, which are produced 
as flat 2D membranes punctured with homogenous holes (Morris et al., 2014). These 
materials provide structural support and nutrient diffusion to the epithelial cells, but as they 
do not degrade with time, they do not allow cells to be mainly supported by the basement 
membrane. Using porous biodegradable polymer scaffolds can overcome this issue, as such 
the scaffolds eventually allow cells to secrete and form a basement membrane as they 
degrade. 
Most applied biodegradable polymers include PLA, PCL and the co-polymer PLGA, which 
are all FDA-approved for tissue engineering applications. Most synthetic polymers degrade 
through hydrolytic degradation, and the degradation rate depends on the polymer 
hydrophobicity, morphology, molecular weight, surface area and the degradability of the 
polymer backbone (Xiao et al., 2011; Agrawal, 2013). The selection of a polymer with a 
suitable degradation rate was a crucial aspect in this research. It was important to develop a 
porous polymer membrane that could provide structural support to the cells while allowing 
the cells to synthesize their own basement membrane as the polymer degraded. Unlike 
PLGA, it is well known that PLA degrades more slowly due to its hydrophobic 
characteristic, and PLA exists in two forms, i.e. PLLA and PDLA, which both have the same 
chemical structure. However, PLLA was chosen for its slow degradation features, as it is a 
crystalline polymer unlike PDLA, which is an amorphous polymer (Rasal et al., 2010; Xiao 
et al., 2011). Degradation assays performed over 6 weeks allowed the demonstration of a 
slow and desirable degradation rate of the PLLA membranes, which is believed to be optimal 
for this culture model. 
The Transwell membranes were considerably thicker than the electrospun PLLA membranes 
presented in this study. This created a greater distance between the HBEpiC and fibroblast 
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layers, which could have affected the paracrine interactions between the cell layers, thus 
negatively influencing HBEpiC differentiation and proliferation (Kobayashi et al., 2006; 
Morris et al., 2014). Furthermore, the PLLA fibres facilitated the elongation and growth of 
both cell types, which could explain the enhanced proliferation of the epithelial cells on the 
electrospun PLLA membranes. 
 
The abovementioned studies enabled the establishment of a long-term in vitro ALI co-
culture consisting of an epithelial cell monolayer and an underlying dermal fibroblast layer. 
How the in vitro ALI culture model enables well-differentiated and polarised HBEpiCs 
while allowing the cells to synthesize a microenvironment resembling the basement 
membrane due to the deposition of both Col IV and LM was demonstrated. Moreover, how 
slow-degrading electrospun PLLA membranes are suitable for supporting HBEpiC 
differentiation in long-term co-culture with fibroblasts was also demonstrated. 
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6. In Vitro Asthma Model  
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6.1 Introduction  
Asthma is a common chronic respiratory disease affecting approximately 300 million people 
worldwide, and while the mortality rate is generally decreasing, asthma still causes 90–170 
deaths per million. Furthermore, in Europe, direct and indirect cost burdens of 509 euros for 
controlled asthma and 2,281 euros for uncontrolled asthma per patient per year have been 
reported (Parker et al., 2013; Bagnasco et al., 2016). Both inflammatory and structural 
modifications are associated with asthma, including epithelial denudation, goblet cell 
metaplasia, airway smooth muscle hypertrophy and changes in the ECM such as increased 
basement membrane production (Figure 6.1) (Mauad et al., 2007; Parker et al., 2013).  As 
previously stated, the airway epithelial cells function as a barrier against external 
microorganisms and allergens. Once the epithelium comes into contact with such allergens 
or microorganisms, the epithelial cells can activate TH2 cells, which secrete cytokines such 
as IL-4 and IL-13. Both cytokines play a key role in the pathogenesis of asthma and were 
some of the first TH2-secreted cytokines identified in the early 1980’s (Parker et al., 2013).  
Both IL-4 and IL-13 can activate IL-4 receptor α subunit (IL-4Rα) on goblet cells, airway 
smooth muscle cells, fibroblasts and macrophages, while only IL-4 stimulates the γC subunit 
on TH2 cells, B cells, eosinophils and macrophages (Figure 6.2). IL-13 activates the IL-13 
receptor α1 subunit (IL-13Rα1) and induces various cellular reactions, including increased 
goblet cell differentiation. These cell surface receptors are found on bronchial epithelial 
cells, airway smooth muscle cells, fibroblasts, eosinophils, B cells and macrophages (Pelaia 
e Vatrella, 2017). Both IL-4 and IL-13 have been linked to mucus hypersecretion (Steinke e 
Borish, 2001; Parker et al., 2013); Gomperts et al. (2007) have reported that IL-13 reduces 
epithelial cell ciliation (Kondo et al., 2006; Gomperts et al., 2007). The reduced ratio of 
ciliated epithelial cells and goblet cells leads to airway remodelling and poor mucociliary 
clearance in the airway, which is otherwise vital for removing harmful microorganisms and 
antigens. Abnormal mucociliary clearance results in mucus accumulation, affecting airway 
function and increasing the occurrence of secondary airway infection (Yang et al., 2004; 
Gomperts et al., 2007; Bagnasco et al., 2016).  
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Figure 6.1. Comparison of normal airway and asthmatic airway. Environmental and genetic 
factors can induce airway inflammation and airway remodelling, resulting in mucus 
hypersecretion, epithelial damage, basement membrane thickening, increased fibroblasts 
and smooth muscle cells, eosinophil and T cell infiltration and angiogenesis. Figure adapted 
from Blume et al. (Blume e Davies, 2013). 
 
Conventional treatments for asthma include inhaled corticosteroids with or without long-
acting b2 agonists and have been widely used to reduce and control asthma symptoms. 
Although traditional corticosteroids treatment eases asthma symptoms and exacerbations, 
approximately 40% of asthma patients continue to have symptoms, while 5% have 
uncontrolled asthma. Moreover, inhaled corticosteroids have no effect on airway 
remodelling (Heaney e Robinson, 2005; Mauad et al., 2007; Parker et al., 2013). Currently, 
several promising new drug treatments, including human monoclonal antibodies targeting 
IL-4 and IL-13, are being investigated, and clinical studies have suggested that these 
antibodies potentially improve lung function and the exacerbation rate of asthma patients 
(Nixon et al., 2017; Ntontsi et al., 2018).  
 
In this chapter, the aim is to investigate the possibility of applying the established in vitro 
bronchial mucosa model as an in vitro asthma mucosa model. Most airway models are 
derived from animals or ex vivo human donor airway tissues. However, these models provide 
either less accurate representation of in vivo human airway tissue, as in the case of animal 
models, or have short viability, as in the case of ex vivo tissues. Hence, both tissue models 
are not considered ideal for drug treatment studies or suitable for studies aimed at improving 
understanding of airway diseases. In vitro human airway models are more representative 
tissue models and could potentially replace animal and ex vivo tissue models (Blume e 
Davies, 2013; Benam et al., 2015). By introducing IL-13, the intention of this research 
project is to achieve goblet cell metaplasia, mucus hypersecretion and reduced epithelial cell 
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ciliation. Additionally, the effect of eliminating IL-13 on airway remodelling and mucin 
hypersecretion after treating HBEpiCs with IL-13 was investigated. Furthermore, the effect 
of dexamethasone on human bronchial epithelial cell mucin secretion was investigated. 
Dexamethasone is a corticosteroid and inhibits MUC2 and MUC5AC protein expression in 
some airway epithelial cell lines. However, the various airway epithelial cell lines and 
primary animal airway epithelial cells respond differently to dexamethasone (Lu et al., 2005; 
Gu et al., 2014).  
 
 
Figure 6.2. Schematic illustration of cellular structural and inflammatory responses to IL-4 
and IL-13. Once airway epithelial cells have been exposed to external allergens and 
microorganisms, TH2 cells are activated, in return producing and secreting IL-4 and IL-13. 
The cytokines trigger various cellular reactions, including goblet cell metaplasia and mucus 
hypersecretion, by activating receptors such as IL-4Rα and IL-13Rα1. Figure adapted from 
Bagnasco et al. (Bagnasco et al., 2016). 
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way epithelial cells and smooth muscle cells  [28] . The re-
ceptor is a heterodimer complex of IL-13Rα and IL-4Rα. 
Circulating IL-13 firstly engages the IL-13Rα1 subunit 
and this event leads to the recruitment of IL-4Rα. The 
binding to theIL-13Rα1/IL-4Rα complex initiates the ac-
tivation of multiple transduction pathways including ty-
rosine kinase 2 (Tyk-2) and Janus kinase 1 (JAK1), which 
are associated with the IL-13R subunit  [29] . The activa-
tion of these transduction systems induces the phosphor-
ylation and activation of the proteins, signal transducer 
and activator of transcription 6 (STAT6) and insulin re-
ceptor substrate 2 (IRS-2)  [29] , which move from the cy-
 Fig. 1. Diagram of the potential cellular effects of IL-4 and IL-13 
on inflammatory and structural cells in asthma. After interaction 
with noxious agents, including allergens, viruses and proteases, 
pulmonary epithelial cells can produce TSLP, IL-25 and IL-33. 
These cyt kines activate specific receptors on ILC2s and drive 
their expansion. Activated ILC2s are central mediators of type 2 
immune responses in the lung. Once activated, ILC2s and mast 
cells produce several cytokines including IL-13. IL-13 induces sev-
eral cellular changes in the airways including goblet cell hyperpla-
sia and mucus production, airway smooth muscle cell prolifera-
tion, fibroblast proliferation and polarization of alternatively acti-
vated macrophages. IL-4, produced by TH2 cells and basophils, 
activates alternatively activated macrophages and eosinophils and 
induces IgE synthesis from B lymphocytes and plasma cells. IgE 
binds to FcεRI receptors on human mast cells and basophils. IgE 
cross-linking by allergens induces the release of histamine, cys-
leukotrienes (Cys-LTs), PAF, prostaglandin D 2 (PGD 2 ), cytokines 
and chemokines that are responsible for some of the symptoms of 
asthma. 
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6.2 Materials and Methods  
HBEpiCs and hTERT dermal fibroblasts were cultured as described in Section 3.4, Air–
Liquid Interface Culture. 
 
Cell morphology was assessed with SEM, see Section 3.7, Cell Morphology Assay. 
 
HBEpiCs were immunostained for E-cadherin and MUC5AC and with DAPI as described 
in Section 3.5, ALI Culture, and visualised with epifluorescence microscopy. 
 
ELISA was used to quantify MUC5AC as specified in Section 3.6, Enzyme-linked 
Immunosorbent Assay, Mucus Secretion. 
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6.3 Results 
6.3.1 IL-13 Reduces Ciliation of HBEpiCs  
To study the impact cytokine IL-13 has on ciliation of primary human bronchial epithelial 
cells, IL-13 at 20ng/ml was freshly added to HBEpiC and dermal fibroblast ALI co-cultures 
as previously described. After two or four weeks of co-culture, the presence of ciliae was 
assessed with SEM of the HBEpiCs. The number of ciliated HBEpiCs was remarkably 
reduced after two weeks of ALI co-culture (Figure 6.3) in comparison with the established 
in vitro bronchial mucosa model. Furthermore, the SEM images showed a complete loss of 
cilia after week 4 of ALI co-culture for the IL-13–induced cultures (Figure 6.3).  
The presence of mucin-secreting HBEpiCs was investigated to determine the role of IL-13 
in HBEpiC differentiation into goblet cells. Positive MUC5AC expression, indicating mucin 
secretion, was observed among the IL-13–treated HBEpiCs after 2 and 4 weeks’ ALI co-
culture; untreated HBEpiCs did not express MUC5AC until week 4 (Figure 6.4). 
Fluorescence images of the IL-13–treated HBEpiCs showed increased MUC5AC expression 
compared to the untreated cells (Figure 6.4).  After 4 weeks’ ALI culture, MUC5AC levels 
were measured with ELISA, as described in Chapter 3. MUC5AC secretion was significantly 
higher for IL-13–treated ALI co-cultures in comparison to cultures not treated with IL-13 
(Figure 6.5).  
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Figure 6.3. SEM images of HBEpiCs co-cultured with dermal fibroblasts in ALI with 
(+IL13) or without IL-13 (-Il13). ALI co-cultures without IL-13 showed ciliated HBEpiCs 
after two and four weeks while co-cultures treated with IL-13 showed non-ciliated HBEpiCs, 
confirming IL-13 reduces ciliation of HBEpiCs. Scale bar = 20m.   
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Figure 6.4. MUC5AC and E-cadherin expression in HBEpiCs co-cultured with hTERT 
dermal fibroblasts in ALI with (+IL13) or without IL-13 (-IL13) for two and four weeks. 
MUC5AC was expressed by all HBEpiCs except for 2 weeks ALI -IL13 HBEpiCs cultures. 
Honeycomb structured E-cadherin adherence junctions were expressed by HBEpiCs 
cultured with and without IL-13. The cells were stained for E-cadherin (green) and 
MUC5AC (red), and the nuclei were stained with DAPI (blue). Scale bar = 50m.   
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Figure 6.5. ELISA showing MUC5AC levels in HBEpiCs co-cultured with hTERT dermal 
fibroblasts in ALI culture. The cells were cultured without IL-13 (Bronchial Mucosa) or with 
IL-13 (Asthma Mimicking) for 4 weeks. ***p < 0.001. 
 
6.3.2 Addition of Dexamethasone and Exclusion of IL-13  
HBEpiCs were treated with dexamethasone to evaluate the effect of dexamethasone on 
MUC5AC expression and secretion. HBEpiCs and hTERT dermal fibroblasts were co-
cultured in ALI culture, as previously described, for 2 weeks with or without IL-13. Once 
the ALI co-cultures were established, 1 µg/mL dexamethasone was freshly added to the cell 
culture medium every 48 hours, and the co-culture was cultured for an additional 2 weeks. 
The dexamethasone concentration was determined based on previous asthma studies (Kanoh 
et al., 2011). HBEpiCs were stained for MUC5AC to examine mucin secretion. Fluorescence 
imaging showed reduced MUC5AC expression in dexamethasone-treated HBEpiCs cultured 
in the in vitro bronchial mucosa model; MUC5AC expression was more prominent in the in 
vitro asthma-mimicking mucosa model (Figure 6.6).  
 
To investigate the effect of IL-13 on HBEpiC MUC5AC secretion, the cytokine was 
excluded from the cell culture medium after 2 weeks and the cells were cultured for 2 
additional weeks without IL-13. Like the dexamethasone-treated HBEpiCs, the cells were 
stained for MUC5AC to determine the presence of the protein. This was done 2 weeks after 
the addition of dexamethasone or 2 weeks after the exclusion of IL-13. Unlike the asthma-
mimicking model, MUC5AC was reduced in the bronchial mucosa model when IL-13 was 
excluded from the culture medium (Figure 6.6).  
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Figure 6.6. Immunofluorescence images of HBEpiCs co-cultured in ALI with hTERT 
dermal fibroblasts for four weeks in cell culture medium without IL-13 (Bronchial Mucosa), 
(B) with IL-13 (Asthma Mimicking), (C) with Dexamethasone and IL-13 (Dex+IL13) and 
(D) with Dexamethasone only (Dex-IL13). (E) IL-13 was excluded from the cell culture 
medium in the last two weeks of the four weeks of ALI co-culture (-IL13 last 2w of ALI). 
The cells were stained for E-cadherin (green) and MUC5AC (red), and the nuclei were 
stained with DAPI (blue). Scale bar = 50µm 
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The MUC5AC levels were quantified with ELISA (Figure 6.7). With or without IL-13, 
dexamethasone significantly decreased MUC5AC levels in HBEpiCs compared to the cells 
cultured in the asthma model. However, it was difficult to see the difference in MUC5AC 
expression of the dexamethasone-treated HBEpiCs and HBEpiCs from the asthma model 
solely from the MUC5AC immunostaining (Figure 6.6). A significant reduction of 
MUC5AC levels was likewise observed for HBEpiCs cultured in ALI co-cultures from 
which IL-13 had been excluded from the cell culture medium in the last 2 weeks of the co-
culture. This decrease could also be observed from the immunostaining (Figure 6.6) of 
HBEpiCs in the asthma model and in HBEpiCs where IL-13 was excluded from the cell 
culture medium in the last 2 weeks of the ALI co-culture. Furthermore, HBEpiCs treated 
with dexamethasone or HBEpiCs cultured in cell culture medium where IL-13 was excluded 
in the last 2 weeks of the ALI co-culture had significantly lower MUC5AC levels compared 
to cells cultured in the in vitro bronchial mucosa models. 
 
 
 
Figure 6.7. ELISA showing MUC5AC levels of HBEpiCs co-cultured with hTERT dermal 
fibroblasts in ALI culture. The cells were cultured without IL-13 (Bronchial Mucosa) or with 
IL-13 (Asthma Mimicking) for 4 weeks. Dexamethasone was added to cultures with or 
without IL-13 (Dex + IL13 or Dex -IL13, respectively). IL-13 was excluded from the cell 
culture medium in the last 2 weeks of the 4-week ALI co-culture (-IL13 (last 2w of ALI)). 
***p < 0.001, ****p < 0.0001. 
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6.4 Discussion and Conclusions  
Asthma is a complex structural and inflammatory disease triggered by various genetic and 
environmental factors. Its complexity renders the establishment of representative in vitro 
asthma models difficult; currently, the majority of established models cover few mechanisms 
of the disease. Due to the complexity of asthma, several studies have used patient- or donor-
derived ex vivo asthmatic tissue. Unlike in vitro ALI culture models, these models are well-
known for their simplicity and ability to retain the natural asthmatic tissue structure (Blume 
e Davies, 2013). Such ex vivo asthmatic tissues have been crucial for understanding the 
importance of TH2 cells in inflammatory diseases such as asthma (Blume e Davies, 2013).  
Although ex vivo airway tissues have been widely used to study asthma, the duration for 
using such tissues experimentally is limited as the duration of exposure to the external 
environment and allergens increases. This renders ex vivo tissue models more suitable for 
short-term studies (Blume e Davies, 2013). Another challenge to using ex vivo tissue 
involves finding sufficient human donors to voluntarily donate airway tissue that allows the 
study of asthma. The most well-established asthma models are animal models derived from 
mice, rats and guinea pigs, among others, which have all increased knowledge and 
understanding of the role of TH2 cells in asthma. Nevertheless, it is crucial to be aware that 
such animal models do not represent human asthma, especially severe asthma (Blume e 
Davies, 2013; Aun et al., 2017). For example, there are some differences in the 
immunological responses of animals and humans, which is important in asthma. In rodents, 
mast cells secrete serotonin upon activation and in return affect airway smooth muscle 
contraction, an immunological response that is not characteristic of human mast cells (Blume 
e Davies, 2013).  
 
In the present work, the aim was to investigate the possibilities of converting the established 
in vitro bronchial mucosa model to an in vitro asthma-mimicking tissue model. An in vitro 
asthma-mimicking epithelial layer could be developed by introducing IL-13, a cytokine that 
plays a key role in the pathogenesis of asthma. IL-13 caused goblet cell metaplasia, as the 
number of ciliated epithelial cells decreased drastically in its presence, and MUC5AC levels 
were increased, indicating mucus hypersecretion. Kondo et al. (2006) reported similar 
epithelial cell responses when human recombinants of IL-13 were introduced into primary 
guinea pig airway epithelial cells (Kondo et al., 2006). However, unlike animals, severe 
asthma in humans is not only an inflammatory reaction, but also involves airway remodelling 
as a result of increased IL-13 levels (Blume e Davies, 2013).  The gold standard for treating 
asthmatic attacks currently includes inhaled glucocorticosteroids, which help the 
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inflammatory reaction such as by reducing mucus hypersecretion (Mauad et al., 2007; 
Kanoh et al., 2011). Dexamethasone is a glucocorticosteroid and was used to assess the 
validity of the established asthma model by investigating whether it could induce lower 
mucus secretion (Kai et al., 1996). ELISA showed that dexamethasone-treated HBEpiCs 
expressed significantly lower MUC5AC levels compared to HBEpiC cells cultured in the 
asthma-mimicking models. Remarkably, the dexamethasone-treated HBEpiCs expressed 
lower levels of MUC5AC in comparison with HBEpiCs cultured in the bronchial mucosa 
models. This suggests that dexamethasone can induce low MUC5AC levels even in non-
inflammatory epithelial cells. The reduction in mucin secretion observed in the 
dexamethasone-treated HBEpiCs was similar to the reaction to inhaled glucocorticosteroids 
used for treating asthma (Mauad et al., 2007; Kanoh et al., 2011). 
Although inhaled glucocorticosteroids remain the preferred treatment for asthma, they have 
been associated with epithelial cell apoptosis. Additionally, it has been suggested that 
glucocorticosteroids do not help with severe and uncontrolled asthma, where airway 
remodelling is known to occur. Based on this knowledge of glucocorticosteroids and the role 
of cytokines such as IL-4 and IL-13 in asthma, numerous studies have investigated 
alternative asthma drug treatments (Yang et al., 2004; Nixon et al., 2017; Korenblat et al., 
2018). Such treatment involves using human monoclonal antibodies to neutralise IL-4 and 
IL-13 or to block the cytokines, inhibiting activation of IL-4– and IL-13– specific receptors. 
One such monoclonal antibody treatment is lebrikizumab, which binds to soluble IL-13 and 
blocks the signalling pathways of activated IL-13 receptors, preventing the cytokine from 
binding. However, although showing promise for treating moderate to severe asthma, these 
novel drugs are still being clinically investigated and are not commercially available 
(Bagnasco et al., 2016; Simpson et al., 2018). Thus, the approach of excluding IL-13 from 
the cell culture medium in the last 2 weeks of the four week ALI co-culture was used in the 
present study to investigate whether it would reduce airway remodelling and mucus 
hypersecretion. Decreased MUC5AC levels were demonstrated following the exclusion of 
IL-13 from the cell culture medium. Nevertheless, it is recommended to investigate any 
HBEpiC reciliation when IL-13 is excluded from the culture. 
 
 
 
 
 111 
7. Discussion and Conclusions  
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Initially the goal of this research was to investigate tissue engineering approaches that could 
facilitate the development of an in vitro human oviduct mucosa consisting of oviduct 
epithelium and an underlying loose connective tissue. Tissue engineered in vitro models of 
the female reproductive system, such as in vitro oviduct models, are needed to understand 
fertilisation and early embryonic development, which potentially have a major effect on 
future infertility treatments (Schenke-Layland e Brucker, 2015). The oviduct mucosa plays 
a vital role in human reproduction, and in vitro models of the tissue could potentially give 
rise to new fertility treatments for patients undergoing in vitro fertilization (IVF) treatments. 
In addition, recent studies have emphasized the importance of oviduct mucosa in serous 
ovarian carcinoma, as it has been implicated that secretory oviduct epithelial cells might be 
the cells of origin of ovarian carcinomas (Jarboe et al., 2009). Although several in vitro 
oviduct models have been established, containing mainly an epithelial monolayer, many of 
these models primarily use animal-derived cells such as porcine oviduct epithelial cells, and 
human cell lines (Miessen et al., 2011; Chen et al., 2013). Currently there is an on-going 
project aiming to develop in vitro oviduct mucosa based on the established ALI system and 
using HOEpiCs obtained from donor oviducts of patients in Denmark due to the lack of 
commercially available primary HOEpiCs.   
The focus of this research was shifted to develop an in vitro bronchial mucosa due to the 
similarities of bronchial and oviduct epithelial cell morphology, including cell shape and the 
presence of both ciliated and secretory epithelial cells (Johnson, 1991; Martini et al., 2012).  
 
This research introduces a novel in vitro bronchial mucosa model using ALI culture. The 
thesis addresses various aspects of the model, including the development of a biodegradable 
membrane cell culture, the proteins used to promote cell attachment and growth, and the 
culture techniques used to stimulate cell differentiation. Additionally, the application 
possibilities of the bronchial mucosa model were investigated. This was done by converting 
the model into an in vitro asthmatic tissue model and using conventional asthma treatment 
drugs such as corticosteroids to assess its validity. 
 
Engineered airway models for clinical use aiming to reconstruct airway tissue and repairing 
the tissue after injury or airway disease have been extensively researched with some progress 
of developing tissue engineered airway models. Nevertheless, these tissue engineered 
models have yet been used clinically. Some researches have been done on the use of 
biodegradable polydioxanone airway stents in patients with tracheal stenosis as an 
alternative to metallic or silicone stents (Dutau et al., 2015). However, these stents have 
shown to relieve the stenosis short-term (4-5 months) after implantation leading to 
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recurrence of airway narrowing after degradation of the stents. PLLA have been indicated 
as a promising airway stent for clinical use as these stents showed longer degradation time 
of 14 months promoting epithelial differentiation and re-vascularation in rabbits (Saito et 
al., 2002). However, no studies have yet been published using PLLA airway stent in human.   
There is still a need for a comprehensive understanding of the mechanisms that are involved 
in tissue generation in engineered artificial microenvironment and of cell-material 
interaction (Noutsios e Pantazaki, 2018). As a result, numerous studies have been conducted 
to develop in vitro tissue models to better understand these mechanisms and to develop novel 
and improved methods for diagnosis, prevention and treatment (Dimova et al., 2005; Chen 
et al., 2013; Benam et al., 2015). Ideally, in vitro tissue models should be an exact replica 
of the natural tissue in vivo and create the same cell microenvironment in vitro as in vivo. 
This can be challenging due to various mechanical and chemical factors that should be 
considered prior to engineering such models (Lanza, 2011). For example, scaffolds can be 
designed to mimic the natural cell microenvironment by altering scaffold topography and 
stiffness and/or by treating the scaffold surface with ECM proteins such as FN and collagen 
(Lanza, 2011; Benam et al., 2015). Various studies have looked at establishing in vitro 
airway models other than the conventional 2D ALI models, including a tri-culture of 
epithelial cells, fibroblasts and dendritic cells, and a small airway-on-a-chip model. The tri-
culture model consists of three electrospun PET membranes cultured separately with the 
Calu-3 epithelial cell line, MRC5 fibroblasts and dendritic cells (Harrington et al., 2014). 
The scaffold containing the dendritic cells is sandwiched between an upper scaffold seeded 
with the epithelial cells and a lower scaffold seeded with the fibroblasts, and the system is 
cultured in ALI to promote epithelial cell differentiation. Paracrine interactions also occur 
between epithelial cells and immune cells such as dendritic cells when the epithelial barrier 
is attacked. The immune cells trigger immune responses such as cytokine release and play a 
key role in restoring good epithelial barrier function. Harrington et al. (2014) demonstrated 
a robust tri-culture airway model with a mucin-secreting epithelium, ECM protein secretion 
from the cells and dendritic cell migration towards the epithelial layer upon exposure to 
allergens (Harrington et al., 2014). Nevertheless, the study did not address epithelial cell 
ciliation. Benam et al. (2016) developed a small airway-on-a-chip model using a 
polydimethylsiloxane (PDMS) microfluidic device and polyester membranes (Benam et al., 
2016). The membranes were seeded with primary human bronchial epithelial cells and 
cultured with a constant culture medium flow, followed by ALI culture for a few weeks. 
Endothelial cells were then seeded on the basal side of the membranes to establish an 
underlying microvascular endothelium. The study demonstrated a well-differentiated 
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epithelial layer containing ciliated and mucin-secreting epithelial cells with well-established 
intercellular tight junctions. In addition, the model was converted into an airway disease 
model by introducing IL-13, and the study reported goblet hyperplasia, similar to the present 
findings. Although the airway-on-a-chip model is promising as an in vitro airway model, it 
is important to not overlook the paracrine interactions between the epithelial cells and the 
underlying cells, i.e. the fibroblasts and immune cells (Kobayashi et al., 2006; Morris et al., 
2014). Moreover, both in vitro models use non-degradable semi-permeable membranes, 
which are commonly used in most ALI culture systems. Such membranes include the PET 
membranes attached to cell culture inserts and have homogeneously ordered holes with a 
diameter of approximately 0.4 m (Even-Tzur et al., 2010). Biodegradable thin polymer 
scaffolds that mimics the basement membrane of the mucosa is highly desirable when tissue 
engineering epithelium. Such scaffolds provide a temporarily mechanical support for the 
epithelial layer while the epithelium secretes its own basement membrane by secreting Col 
IV and LM and prevent migration of epithelial cells to underlying tissue and promotes 
epithelialisation. Bye et al. (2013, 2014) have shown the importance of using engineered 
artificial basement membrane to create a separation between the epithelial layer and the 
underlying connective tissue preventing migration of epithelial cells and stromal cells (Bye 
et al., 2013; Bye et al., 2014). In the present project, it was shown that non-degradable 
membranes such as Transwell membranes do not support epithelial cell proliferation and 
differentiation and were considerably thicker compared to the electrospun PLLA 
membranes. Thus, it created greater proximity between the HBEpiCs and fibroblasts and 
possibly affected the paracrine interaction between the two cell types (Harrington et al., 
2014; Morris et al., 2014; Benam et al., 2015). Furthermore, the thicker PET membranes 
might have affected the nutrient diffusion from the basal side to the epithelial cells in the 
ALI culture, leading to poor HBEpiC proliferation (Goers et al., 2014; Morris et al., 2014). 
Unlike PET membranes, which have homogenously organised holes, electrospinning made 
it possible to control the fibre thickness and pore sizes of the PLLA membranes by adjusting 
electrospinning parameters such as applied voltage, polymer solution concentration and/or 
gap distance between the needle and collector(Fujihara et al., 2005; Bhardwaj e Kundu, 
2010). Although PLLA is a biodegradable polymer, it was shown that these membranes can 
still provide structural support for in vitro mucosa over a period of at least 4 weeks while 
allowing cells to secrete their own ECM (Xiao et al., 2011).  
 
Throughout the project, the importance of an intermediate protein layer between cells and 
polymer surfaces was demonstrated using three proteins, i.e. Col IV, FN and LM. Han et al. 
(2006) have suggested FN to promote proliferation of human bronchial epithelial cells cell 
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lines such as BEAS-2B and 16-HBE and prevent apoptosis (Han e Roman, 2006). With this 
project, it was observed that FN promoted better cell adhesion and proliferation among 
HBEpiCs and fibroblasts compared to Col IV and LM. In addition, FN decreased the 
hydrophobicity of the PLLA membranes, increasing the cell affinity of the membranes and 
cell attachment. 
 
The majority of the established in vitro mucosa models use single culture of epithelial cells 
on the apical side of the membranes, overlooking the importance of the underlying 
connective tissue cells such as fibroblasts (Kobayashi et al., 2006; Lin et al., 2007). This 
project focused on developing an ALI co-culture system that incorporates fibroblasts on the 
basal side of the membranes to create a more in vivo–like model of the mucosa. The results 
demonstrated not only the importance of using ALI for epithelial cell differentiation but also 
the vital role of the underlying fibroblast layer in epithelial cell ciliation(Kobayashi et al., 
2006; Morris et al., 2014). The established bronchial mucosa model promotes epithelial cell 
differentiation into ciliated and mucin-secreting HBEpiCs when epithelial cells are cultured 
in ALI and with an underlying fibroblast layer. The membrane thickness used in the ALI 
culture played a role in HBEpiC proliferation, as thicker PET membranes reduced HBEpiC 
proliferation. 
 
Another important aspect of establishing the in vitro model was choosing primary cells or 
cell lines. Primary cells derived from either animals or humans exhibit a more representative 
cellular interaction than cell lines; however, these cells can be difficult to harvest and can 
vary between each isolation. This was observed during the initial attempts to isolate the 
HOEpiCs, as the cell numbers and viable cells isolated from donor oviducts would vary 
between each donor tissue. Cell lines are more reproducible and homogeneous and are 
widely used for toxicological and pathogen behavioural studies despite their poor 
differentiation. Additionally, they are cancerous and thus are not a good representation of 
the normal cell phenotype. Due to their ability to become a polarised epithelial layer as in 
vivo, the Calu-3 and 16HBE14o- cell lines have been used for many in vitro bronchial 
models (Reddel et al., 1995; Grainger et al., 2006).  Primary epithelial cells were used in the 
present project because they exhibit the same cell phenotype as in vivo and differentiate to 
both ciliated and secretory epithelial cells. However, primary human bronchial epithelial 
cells used in in vitro ALI cultures have low transepithelial electrical resistance (TEER) of 
<350 cm2, indicating poor epithelial barrier function (Bhowmick e Gappa-Fahlenkamp, 
2016). Retinoic acid has been used to improve the differentiation of airway epithelial cells 
in ALI cultures, and studies have shown differentiated primary cells and cell lines with tight 
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junctions (Dimova et al., 2005; O'boyle et al., 2018). Nevertheless, as shown here, retinoic 
acid did not enhance HBEpiC differentiation but instead inhibited their ciliation. Thus, 
retinoic acid was eliminated from the cell culture medium. Although collagen is the preferred 
protein coating for many cell culture insert membranes, such as the Transwell PET 
membrane, it was clear from this project that FN promoted better cell attachment and 
proliferation for both HBEpiCs and hTERT dermal fibroblasts. 
 
Although the present in vitro bronchial mucosa model enables cell proliferation and 
epithelial cell differentiation and polarisation, it does not address the 3D environment of 
fibroblasts and the ECM (Edmondson et al., 2014; Shamir e Ewald, 2014) as fibroblasts are 
surrounded by other cells and reside within the ECM in vivo (Rhee, 2009). The presented 
electrospun PLLA membrane allows both epithelial cells and fibroblasts to attach to the 
surface, and no cells resided inside the membrane pores. Morris et al. (2014) established a 
3D biphasic electrospun PET scaffold for in vitro airway culture modelling to investigate 
cellular interaction in a 3D in vitro ALI culture model as compared to the conventional 2D 
ALI culture models. They showed that microfibre scaffolds improved the proliferation of 
fibroblasts residing in the pores of the electrospun scaffold compared to fibroblasts attached 
to the surface of the nanofibre scaffold. Bott et al. (2010) also suggested improved fibroblast 
proliferation in 3D cell cultures involving hydrogels (Bott et al., 2010), and various other 
studies have suggested different cellular behaviour of cells cultured in 2D versus 3D 
microenvironments (Smithmyer et al., 2014; Park et al., 2016). For example, fibroblasts 
cultured in conventional 2D conditions exhibit flat and elongated cell morphology compared 
to fibroblasts cultured in collagen gels, which spread and form a 3D cell network (Rhee, 
2009).  Compared to 2D cultures, 3D matrices allow different cell adhesion sites and 
physical barriers due to the distribution of the cells in the 3D matrices. This might have an 
effect on integrin binding and signalling pathways, which in return influence cellular 
behaviour (Bott et al., 2010). Some additional studies outside the scope of this project were 
initiated at the Fraunhofer Institute, Stuttgart, Germany, to investigate the possibilities of 
developing a biphasic scaffold that could provide a 3D structural environment for 
fibroblasts. The scaffold consisted of electrospun PLLA membranes adhered to collagen 
hydrogels entrapped with dermal fibroblasts. The study was discontinued due to time 
limitations; however, investigating the cellular interactions of the in vitro bronchial mucosa 
model using the developed biphasic scaffold entrapped with fibroblasts is recommended. 
 
To ensure that the developed bronchial mucosa model is suitable for in vitro studies, the 
model was converted to an in vitro asthma model. Corticosteroids are the most commonly 
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used drug for asthma treatment (Heaney e Robinson, 2005; Mauad et al., 2007). To evaluate 
whether the established asthma model exhibited the same reaction to corticosteroids 
reduction of mucin secretion as in vivo, dexamethasone was added to the culture medium. 
Asthma is currently one of the most common pulmonary diseases and was chosen as a 
disease model due to the numerous studies already conducted and the simplicity of triggering 
asthmatic reaction by exposing healthy airway tissue to IL-13. Although reduced mucin 
secretion upon dexamethasone treatment could be demonstrated, it was not possible to show 
reciliation of the epithelial cells. Thus, a future option for the asthma model could be to use 
human monoclonal antibodies targeting IL-13 to investigate whether such antibodies could 
stimulate the ciliation of HBEpiCs exposed to IL-13 (Nixon et al., 2017; Korenblat et al., 
2018; Ntontsi et al., 2018).  
 
By using an ALI co-culture system consisting of FN coated PLLA membranes, HBEpiCs 
and fibroblasts, this research was able to establish a novel in vitro bronchial mucosa model 
mimicking the in vivo cell morphology and the microenvironment in the basement 
membrane. This work suggests an ALI co-culture system that would be suitable for acting 
as an in vitro disease model for studying airway diseases such as asthma and could be a 
possible model for asthma drug screening. The established in vitro bronchial mucosa model 
could be suitable for investigating and understanding key mechanisms involved in airway 
diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and airway 
repair. Moreover, this research offers a novel approach of using biodegradable polymer 
scaffolds that can potentially be suitable for future clinical use to regenerate functional 
airway epithelium for patients with tracheal stenosis or carcinoma. The presented 
biodegradable electrospun PLLA membranes indicate PLLA as a potential biodegradable 
polymer for artificial airway grafts or airway stents for humans to promote formation of a 
functional airway epithelium in vivo.  
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